<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">107651</article-id>
<article-id pub-id-type="doi">10.7554/eLife.107651</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107651.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories><title-group>
<article-title>The hypoxic response extends lifespan through a bioaminergic and peptidergic neural circuit</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3414-1509</contrib-id>
<name>
<surname>Kitto</surname>
<given-names>Elizabeth S</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="fn" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1867-4794</contrib-id>
<name>
<surname>Huang</surname>
<given-names>Shijiao</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="fn" rid="n1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-4143-2522</contrib-id>
<name>
<surname>Bhandari</surname>
<given-names>Mira</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0003-7673-7295</contrib-id>
<name>
<surname>Tian</surname>
<given-names>Cassie</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6251-087X</contrib-id>
<name>
<surname>Cox</surname>
<given-names>Rebecca L</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8068-3953</contrib-id>
<name>
<surname>Beydoun</surname>
<given-names>Safa</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shave</surname>
<given-names>Danielle</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Hillary A</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0849-8363</contrib-id>
<name>
<surname>Easow</surname>
<given-names>Sarah A</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Henry</surname>
<given-names>Ella</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaller</surname>
<given-names>Megan L</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8003-2955</contrib-id>
<name>
<surname>Leiser</surname>
<given-names>Scott F</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
<email>leiser@umich.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Molecular and Integrative Physiology Department, University of Michigan</institution></institution-wrap>, <city>Ann Arbor</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05p1j8758</institution-id><institution>Department of Biochemistry and Molecular Biophysics, Kansas State University</institution></institution-wrap>, <city>Manhattan</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Cellular and Developmental Biology, University of Michigan</institution></institution-wrap>, <city>Ann Arbor</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Cellular and Molecular Biology Program, University of Michigan</institution></institution-wrap>, <city>Ann Arbor</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Internal Medicine, University of Michigan</institution></institution-wrap>, <city>Ann Arbor</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Lee</surname>
<given-names>Sylvia</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Cornell University</institution>
</institution-wrap>
<city>Ithaca</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Kapahi</surname>
<given-names>Pankaj</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Buck Institute for Research on Aging</institution>
</institution-wrap>
<city>Novato</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>*</label><p>Indicates co-first authors</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-08-26">
<day>26</day>
<month>08</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP107651</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-05-27">
<day>27</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-05-09">
<day>09</day>
<month>05</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.05.04.652087"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Kitto et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Kitto et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-107651-v1.pdf"/>
<abstract>
<title>Abstract</title><p>A coordinated response to stress is crucial for promoting the short- and long-term health of an organism. The perception of stress, frequently through the nervous system, can lead to physiological changes that are fundamental to maintaining homeostasis.</p>
<p>Activating the response to low oxygen, or hypoxia, extends healthspan and lifespan in <italic>C. elegans</italic>. However, despite some positive impacts, negative effects of the hypoxic response in specific tissues prevent translation of their benefits in mammals. Thus, it is imperative to identify which components of this response promote longevity. Here, we interrogate the cell-nonautonomous hypoxic response signaling pathway. We find that HIF-1-mediated signaling in ADF serotonergic neurons is both necessary and sufficient for lifespan extension. Signaling through the serotonin receptor SER-7 in the GABAergic RIS interneurons is necessary in this process. Our findings also highlight the involvement of additional neural signaling molecules, including the neurotransmitters tyramine and GABA, and the neuropeptide NLP-17, in mediating longevity effects. Finally, we demonstrate that oxygen- and carbon-dioxide-sensing neurons act downstream of HIF-1 in this circuit.</p>
<p>Together, these insights develop a circuit for how the hypoxic response cell-nonautonomously modulates aging and suggests valuable targets for modulating aging in mammals.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>F31AG084146-01</award-id>
</award-group>
<award-group id="funding-1a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01AG058717</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/021nxhr62</institution-id>
<institution>National Science Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>DGE1841052</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The global population is aging at an unprecedented rate, posing significant challenges for healthcare systems worldwide<sup><xref ref-type="bibr" rid="c1">1</xref></sup>. The increasing burden of age-related diseases such as cardiovascular disease, diabetes, and neurodegeneration<sup><xref ref-type="bibr" rid="c2">2</xref></sup> highlights the pressing need to improve healthspan, defined as the disease-free period of life<sup><xref ref-type="bibr" rid="c3">3</xref></sup>. Work over the past several decades has led to a better understanding of the conserved molecular and cellular mechanisms that regulate lifespan. One promising avenue has been the identification of environmental stressors that, when applied in a controlled manner, activate stress-response pathways to promote longevity. These interventions, including calorie restriction, exercise, hypoxia, heat shock, and cold exposure, extend lifespan and healthspan<sup><xref ref-type="bibr" rid="c4">4</xref>–<xref ref-type="bibr" rid="c7">7</xref></sup>. These stress-response pathways induce hormesis, a phenomenon in which a low dose of a stressor results in adaptive beneficial effects on cellular function<sup><xref ref-type="bibr" rid="c8">8</xref>,<xref ref-type="bibr" rid="c9">9</xref></sup>.</p>
<p>Hormesis and the underlying stress-responses that promote longevity converge on cellular pathways, including oxidative stress, insulin signaling, autophagy, and protein homeostasis<sup><xref ref-type="bibr" rid="c10">10</xref></sup>, to promote longevity.</p>
<p>Multicellular organisms secrete a highly conserved set of neuromodulators including neurotransmitter and neuropeptide signals from the central nervous system. These signals integrate information about the organism’s external environment and internal state, and coordinate a physiological response in peripheral tissues. Within the context of aging, bioamine neurotransmitters contribute to the activation of many well-studied stress response mechanisms that promote longevity. For example, serotonin signaling modulates the mitochondrial unfolded protein response in <italic>C. elegans</italic><sup><xref ref-type="bibr" rid="c11">11</xref></sup>, and regulates how food perception contributes to dietary restriction-mediated longevity in worms<sup><xref ref-type="bibr" rid="c12">12</xref></sup> and flies<sup><xref ref-type="bibr" rid="c13">13</xref></sup>.</p>
<p>Dopamine also modifies the longevity benefits of dietary restriction in invertebrates<sup><xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c14">14</xref></sup>, and polymorphisms in the dopamine D4 receptor are associated with longevity in humans<sup><xref ref-type="bibr" rid="c15">15</xref></sup>. Finally, adrenaline and its invertebrate analog, tyramine, have been linked to changes in the aging rate in both nematodes<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c16">16</xref>–<xref ref-type="bibr" rid="c18">18</xref></sup> and mammals<sup><xref ref-type="bibr" rid="c19">19</xref></sup>. Hormone signals such as insulin<sup><xref ref-type="bibr" rid="c20">20</xref>–<xref ref-type="bibr" rid="c22">22</xref></sup>, growth factors<sup><xref ref-type="bibr" rid="c23">23</xref>,<xref ref-type="bibr" rid="c24">24</xref></sup>, and GnRH<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c25">25</xref></sup> also contribute to longevity pathways across taxa. This growing body of work has led to great interest in manipulating longevity-promoting neural circuits to improve health<sup><xref ref-type="bibr" rid="c26">26</xref></sup>. While significant research effort focuses on pathways like autophagy, insulin signaling, and proteostasis in the context of aging, the role of hypoxia remains relatively underexplored. Currently, no longevity-promoting agents have been reported to target the hypoxic response.</p>
<p>The hypoxic response is highly conserved across species<sup><xref ref-type="bibr" rid="c27">27</xref>–<xref ref-type="bibr" rid="c29">29</xref></sup>, highlighting the relevance of this pathway in other organisms, including humans. In <italic>C. elegans</italic>, activating the hypoxic response by knocking down or mutating the E3 ubiquitin ligase von hippel-lindau-1 (VHL-1)<sup><xref ref-type="bibr" rid="c30">30</xref></sup> protein or stabilizing the hypoxia-inducible factor-1 (HIF-1) transcription factor<sup><xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c31">31</xref></sup> is sufficient to extend lifespan. All of these interventions—environmental hypoxia, VHL-1 knockdown, and HIF-1 stabilization—require the intestinal enzyme flavin-containing monooxygenase-2 (<italic>fmo-2)</italic> to extend lifespan in <italic>C. elegans</italic><sup><xref ref-type="bibr" rid="c31">31</xref></sup>. Hypoxic conditions also extend lifespan in a short-lived progeria mouse model<sup><xref ref-type="bibr" rid="c32">32</xref></sup>, and epidemiological studies indicate a correlation between hypoxia exposure and longevity<sup><xref ref-type="bibr" rid="c33">33</xref>,<xref ref-type="bibr" rid="c34">34</xref></sup>. However, the physiological changes induced by the hypoxic response are broad and involve adaptations such as increased vascularization, metabolic rewiring, and changes in cell survival pathways. In mammals, some of these same adaptations can be detrimental, as mutations in components of the hypoxic response have been linked to conditions like cancer and cardiovascular disease<sup><xref ref-type="bibr" rid="c35">35</xref>–<xref ref-type="bibr" rid="c38">38</xref></sup>. This presents a key challenge: while hypoxia-induced longevity in a post-mitotic invertebrate model like <italic>C. elegans</italic> is promising, some of the mechanisms involved may not be directly translatable to mammals without causing deleterious side effects. Therefore, a mechanistic understanding of the individual cells, neural circuits, and pathways that mediate the beneficial but not detrimental effects of hypoxia on aging is essential to determine whether this circuit could be leveraged to improve human health.</p>
<p>Our previous work in <italic>C. elegans</italic> identified that stabilization of HIF-1 in neurons is sufficient to extend lifespan through the serotonin receptor, SER-7. This pathway eventually leads to the induction of <italic>fmo-2</italic>, a longevity gene expressed in the intestine<sup><xref ref-type="bibr" rid="c31">31</xref>,<xref ref-type="bibr" rid="c39">39</xref></sup>. In this study, we uncover key neural components of the hypoxic response longevity circuit. Within this circuit, we identify individual cells, signals, and receptors necessary and/or sufficient to extend lifespan downstream of the hypoxic response. More specifically, we find serotonin signaling in the ADF serotonergic neurons is both necessary and sufficient to extend lifespan through the hypoxic response. This pathway signals through the serotonin receptor SER-7 in the RIS interneuron, which is also essential for hypoxia-mediated longevity. We further demonstrate additional neurotransmitters (GABA and tyramine), and a neuropeptide (NLP-17) are critical for mediating these longevity effects. Finally, we identify that oxygen sensing neurons (URX, AQR, PQR and BAG) act downstream of neuronal HIF-1 in this circuit. Our insights into this longevity pathway provide a mechanistic understanding of how the hypoxic response delays aging and improves health.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Serotonin signaling through the ADF neuron and the SER-7 receptor are necessary and sufficient for the hypoxic response to extend lifespan</title>
<p>Induction of the hypoxic response by targeted genetic manipulations can increase lifespan in <italic>C. elegans.</italic> These manipulations include decreasing activity of the VHL-1 E3 ubiquitin ligase that targets the transcription factor HIF-1 for degradation under hypoxia<sup><xref ref-type="bibr" rid="c30">30</xref></sup> or by a mutation that stabilizes HIF-1 (HIF-1<sup>P621A</sup>)<sup><xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c31">31</xref></sup> (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). We previously found that stabilizing HIF-1 in serotonergic neurons is sufficient to extend lifespan<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. To determine which serotonergic neurons initiate HIF-1-mediated longevity, we generated strains with a nondegradable HIF-1 variant (HIF-1<sup>P621A</sup>)<sup><xref ref-type="bibr" rid="c31">31</xref>,<xref ref-type="bibr" rid="c40">40</xref></sup> expressed under promoters specific to each of <italic>C. elegans’</italic> three primary serotonergic neuron types—the ADF, NSM, and HSN neurons<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. These transgenic worms were then crossed into the <italic>hif-1</italic> null background to ensure that HIF stabilization in one neuron type could not feedback to modify HIF-1 activity in other cells. When we measured the lifespan of each strain relative to WT and <italic>hif-1</italic> knockout controls, we observed that stabilizing HIF-1 in the ADF or NSM neurons significantly extended lifespan by 26% and 23%, respectively (<xref rid="fig1" ref-type="fig">Fig. 1B-C</xref>). HIF-1 stabilization in the HSN neurons had a smaller effect but significantly extended lifespan by 9% (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). This result indicates that modifying signaling in any serotonergic neuron is sufficient to induce some level of hypoxic response-mediated longevity. These data suggest that serotonergic neurons can partially substitute for each other to promote longevity in this pathway. In summary, the ADF and/or NSM serotonergic neurons play an essential role in hypoxic response-mediated longevity.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>ADF serotonergic neurons are necessary and sufficient to extend lifespan downstream of the hypoxic response.</title>
<p>(<bold>A</bold>) Diagram of the conserved hypoxic response and genetic approaches to activate it, <italic>vhl-1</italic> knockdown and HIF-1 stabilization. (<bold>B-D</bold>) Survival curves of WT, <italic>hif-1(ia4)</italic> knockout, <italic>hif-1(ia4);</italic> ADF::HIF-1S (<bold>B</bold>), <italic>hif-1(ia4);</italic> NSM::HIF-1S (<bold>C</bold>), and <italic>hif-1(ia4);</italic> HSN::HIF-1S (<bold>D</bold>) worms. <italic>N</italic> ≥ 256 (<bold>B</bold>), <italic>N</italic> ≥ 188 (<bold>C</bold>), and <italic>N</italic> ≥ 188 (<bold>D</bold>) worms per condition. (<bold>E</bold>) Survival curves of WT and ADF:<italic>tph-1</italic> knockout worms on empty vector (EV) or <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 143 worms per condition. (<bold>F</bold>) Survival curves of WT and NSM:<italic>tph-1</italic> knockout worms on empty vector (EV) or <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 193 worms per condition. (<bold>G</bold>) Survival curves of WT and <italic>tph-1(mg280);</italic> ADF:<italic>tph-1</italic> rescue worms on empty vector (EV) or <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 178 worms per condition. (<bold>H</bold>) Survival curves of WT and <italic>tph-1(mg280);</italic> NSM:<italic>tph-1</italic> rescue worms on empty vector (EV) or <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 160 worms per condition. (<bold>I</bold>) Gene expression of <italic>fmo-2</italic> in WT and <italic>hif-1(ia4);</italic> ADF:HIF-1S worms. Significance in panels B-H is from a log-rank test comparing median survival. Significance in panel I is from a Student’s t-test (unpaired, two-tailed). In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001.</p></caption>
<graphic xlink:href="652087v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To further test the necessity of the most impactful (for lifespan) serotonergic neurons in hypoxia-mediated longevity, we used transgenic animals in which <italic>tph-1</italic>, the rate-limiting enzyme in serotonin synthesis, was knocked out exclusively in the ADF or the NSM serotonergic neurons<sup><xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c42">42</xref></sup>. We then measured the lifespans of these strains on empty vector (EV) and <italic>vhl-1</italic> RNAi to determine the necessity of ADF and NSM serotonergic signaling in <italic>vhl-1</italic>-mediated longevity. Successful RNAi knockdown was confirmed with qPCR validation (<xref rid="figs1" ref-type="fig">Fig. S1A</xref>). We found that serotonin synthesis in ADF but not NSM neurons was required for <italic>vhl-1</italic> knockdown to extend lifespan (<xref rid="fig1" ref-type="fig">Fig. 1E-F</xref>). This indicates that while HIF stabilization in multiple serotonergic neurons can extend lifespan, ADF serotonin signaling is required for lifespan extension in response to <italic>vhl-1</italic> knockdown.</p>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 1.</label>
<caption><title>t<italic>ph-1</italic> is required for <italic>vhl-1</italic> mediated longevity.</title>
<p>(<bold>A</bold>) Gene expression of <italic>vhl-1</italic> in worms on <italic>vhl-1</italic> RNAi compared to control worms on empty vector (EV) RNAi for two generations. <italic>N</italic> ≥ 200 worms per replicate, or 1200 worms per condition. The top of the bar represents the mean of the population and error bars indicate standard error of the mean (SEM). (<bold>B</bold>) Survival curve of WT, <italic>vhl-1(ok161)</italic>, <italic>tph-1(mg280),</italic> and <italic>vhl-1(ok161); tph-1(mg280)</italic> worms. <italic>N</italic> ≥ 338 worms per condition. Significance is from a log-rank test comparing median survival. In all panels, NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. Three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To test if serotonin production in a single neuron type is sufficient for the hypoxic response to extend lifespan, we rescued <italic>tph-1</italic> expression in a <italic>tph-1</italic> null background using promoters specific to the ADF or the NSM neurons<sup><xref ref-type="bibr" rid="c12">12</xref></sup>. The lifespans of these strains on EV or <italic>vhl-1</italic> RNAi were then measured. As expected and consistent with our previous publication<sup><xref ref-type="bibr" rid="c31">31</xref></sup>, the lifespan of the <italic>tph-1</italic> knockout strain was not extended by <italic>vhl-1</italic> knockdown (<xref rid="figs1" ref-type="fig">Fig. S1B</xref>). Consistent with the ADF neuron’s requirement for hypoxic response-mediated longevity (<xref rid="fig1" ref-type="fig">Fig. 1E-F</xref>), serotonin synthesis in the ADF neurons was sufficient for <italic>vhl-1</italic> knockdown to extend lifespan while NSM serotonin synthesis was not (<xref rid="fig1" ref-type="fig">Fig. 1G-H</xref>). The enzyme <italic>fmo-2</italic> is induced in the intestine under hypoxia and is required for lifespan extension by environmental hypoxia, HIF-1 stabilization, or <italic>vhl-1</italic> depletion<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. To test whether ADF-specific HIF-1 stabilization also induces <italic>fmo-2</italic>, we measured <italic>fmo-2</italic> transcription in this strain using qPCR. We found that ADF HIF-1 stabilization significantly induced <italic>fmo-2</italic> expression relative to WT controls (<xref rid="fig1" ref-type="fig">Fig. 1I</xref>), suggesting a model in which ADF signaling extends lifespan through the same mechanism as <italic>vhl-1</italic> knockdown and environmental hypoxia. Together, these data indicate that while HIF-1 stabilization in any serotonergic neuron is sufficient to extend lifespan, only ADF serotonin production is necessary and sufficient for <italic>vhl-1-</italic>mediated longevity. This suggests that under normal physiological conditions the serotonergic ADF neurons propagate a signal in response to whole body stabilized HIF-1.</p>
<p>After identifying ADF neurons as the most central serotonergic neurons in hypoxic response-mediated longevity, we next sought to determine the downstream receptor responding to serotonin signaling from ADF neurons. <italic>C. elegans</italic> have six known serotonin receptors—SER-1, SER-4, SER-5, SER-7, MOD-1, and LGC-50. Of these six receptors, our previous findings showed that <italic>ser-7</italic> expression is required for hypoxia to induce <italic>fmo-2</italic> and extend lifespan<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. SER-7 is a G protein-coupled receptor (GPCR) with high sequence identity to the 5-HT<sub>7</sub> receptor in mammals<sup><xref ref-type="bibr" rid="c43">43</xref>,<xref ref-type="bibr" rid="c44">44</xref></sup>. SER-7 is thought to be expressed in 27 of <italic>C. elegans’</italic> 302 neurons<sup><xref ref-type="bibr" rid="c45">45</xref></sup> and contributes to many aspects of physiology such as reproduction and pharyngeal pumping<sup><xref ref-type="bibr" rid="c43">43</xref></sup>. Consequently, broad manipulation of SER-7 signaling is not an ideal method for exclusively modifying aging. To identify more specific targets for lifespan extension within this pathway, we asked whether <italic>ser-7</italic> expression in any subset of neurons is sufficient to rescue the hypoxic response in a <italic>ser-7</italic> null background.</p>
<p>We created transgenic strains with <italic>ser-7</italic> expression under the control of 11 different cell-specific promoters in a <italic>ser-7</italic> null background. These promoters were selected to rescue <italic>ser-7</italic> expression in the following neuronal populations: whole-body rescue (<italic>ser-7p::ser-7)</italic>, interneuron rescue (<italic>glr-1p::ser-7)</italic>, bioaminergic neuron rescue (<italic>cat-1p::ser-7)</italic>, glutamatergic neuron rescue (<italic>eat-4p::ser-7</italic>), GABAergic neuron rescue (<italic>unc-47p::ser-7</italic>), cholinergic neuron rescue (<italic>unc-17p::ser-7</italic>), sensory neuron rescue (<italic>osm-6p::ser-7</italic>), GABAergic motor neuron rescue (<italic>unc-25p::ser-7</italic>), cholinergic motor neuron rescue (<italic>acr-2p::ser-7</italic>), M3 and M4 neuron rescue (<italic>ceh-28p::ser-7</italic>), and intestinal rescue (<italic>vha-6p::ser-7</italic>) in a <italic>ser-7</italic> null background. To measure whether <italic>ser-7</italic> expression restores a WT-like hypoxic response, we injected each construct into <italic>ser-7</italic> null worms crossed with a single-copy transcriptional reporter for <italic>fmo-2 (fmo-2p::mCherry)</italic>. Because <italic>fmo-2</italic> is induced by and required for hypoxia-mediated longevity<sup><xref ref-type="bibr" rid="c31">31</xref></sup>, we utilized its induction as an efficient screening tool to identify components of this longevity pathway.</p>
<p>We first confirmed that <italic>ser-7</italic> knockout attenuates <italic>vhl-1-</italic>mediated <italic>fmo-2</italic> induction (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). The whole-body rescue of SER-7 expression under the endogenous <italic>ser-7</italic> promoter restored <italic>fmo-2</italic> induction to 91% of WT controls (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). Of the 10 cell-specific <italic>ser-7</italic> rescues, expression in interneurons, bioaminergic neurons, glutamatergic neurons, or GABAergic neurons fully rescued <italic>vhl-1</italic>-mediated <italic>fmo-2</italic> induction to ≥ 100% of the WT control response (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>, pink bars). <italic>ser-7</italic> rescue in GABAergic motor neurons or in sensory neurons showed a partial rescue (defined as a 50-99% increase from <italic>fmo-2</italic> induction in the <italic>ser-7</italic> knockout) (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>, orange bars). In contrast, rescuing <italic>ser-7</italic> in cholinergic motor neurons, cholinergic neurons, M3 and M4 neurons, or in the intestine did not rescue (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>, gray bars). Taken together, 6 of the 10 cell-specific <italic>ser-7</italic> rescues at least partially restored <italic>vhl-1-</italic>mediated <italic>fmo-2</italic> induction, including some that have no known overlap in <italic>ser-7</italic> expression patterns. Collectively, these data suggest that serotonin receptor <italic>ser-7</italic> expression in multiple neurons may be sufficient to convey the hypoxic signal to the intestine and induce <italic>fmo-2</italic>.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title><italic>ser-7</italic> expression in the GABAergic RIS neuron is required for hypoxia to extend lifespan.</title>
<p>(<bold>A</bold>) Quantification of <italic>fmo-2p::mCherry</italic> (WT positive control), <italic>fmo-2p::mCherry; ser-7(tm1325)</italic> knockout (negative control), and <italic>fmo-2p::mCherry; ser-7(tm1325)</italic> knockouts with <italic>ser-7</italic> rescued in the whole body (<italic>ser-7p::ser-7)</italic>, interneurons (<italic>glr-1p::ser-7)</italic>, bioaminergic neurons (<italic>cat-1p::ser-7)</italic>, glutamatergic neurons (<italic>eat-4p::ser-7</italic>), GABAergic neurons (<italic>unc-47p::ser-7</italic>), GABAergic motor neurons (<italic>unc-25p::ser-7</italic>), sensory neurons (<italic>osm-6p::ser-7</italic>), cholinergic motor neurons (<italic>acr-2p::ser-7</italic>), cholinergic neurons (<italic>unc-17p::ser-7</italic>), M3 &amp; M4 neurons (<italic>ceh-28p::ser-7</italic>), and the intestine (<italic>vha-6p::ser-7</italic>) on empty vector (EV, WT control shown) or <italic>vhl-1</italic> RNAi (all strains shown). Bar height indicates the mean fluorescence on <italic>vhl-1</italic> RNAi of each genotype normalized to the empty vector control value from that genotype. The dashed line indicates the <italic>vhl-1-</italic>mediated <italic>fmo-2</italic> induction of WT positive control. <italic>N</italic> ≥ 45 worms per condition. Error bars indicate SEM. Significance is from a two-way ANOVA (<italic>fmo-2</italic> induction ∼ genotype*RNAi) and post-hoc Tukey HSD test (unpaired, two-tailed). Stars signify results from this post-hoc test comparing the <italic>fmo-2</italic> induction of each strain on EV RNAi the <italic>fmo-2</italic> induction of that strain on <italic>vhl-1</italic> RNAi. (<bold>B</bold>) A table showing the 10 <italic>ser-7</italic> expressing candidate neurons and their expression patterns among the <italic>ser-7</italic> cell-specific strains that successfully rescued <italic>fmo-2</italic> induction in <xref rid="fig2" ref-type="fig">Fig. 2A</xref>. Pink rows indicate rescues that full restored <italic>vhl-1</italic> mediated <italic>fmo-2</italic> induction, orange rows indicate rescues that partially restored <italic>vhl-1-</italic>mediated <italic>fmo-2</italic> induction, and gray rows signify unsuccessful rescue constructs from the data in <xref rid="fig2" ref-type="fig">Fig. 2A</xref>. (<bold>C</bold>) Survival curve of WT and RIS ablation (<italic>Ex[srsx-18p::caspase-3(p12)-nz]; Ex[srsx-18p::cz-caspase-3 (p17)]; srsx-18p::GFP</italic>) worms on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 192 worms per condition. (<bold>D</bold>) Survival curve of WT and <italic>ser-7 (tm1325); ser-7</italic> rescue in the RIS neuron (<italic>flp-11p::ser-7</italic>) worms on EV and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 144 worms per condition. Significance in panels C-D is from a log-rank test comparing median survival. In all panels, NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We compiled a table containing the top candidates for the <italic>ser-7</italic> neuron based on which rescue constructs restored <italic>ser-7</italic> expression (simplified table in <xref rid="fig2" ref-type="fig">Fig. 2B</xref>, full table in <xref rid="figs2" ref-type="fig">Fig. S2A</xref>). We hypothesized that neurons present in many of the successful rescue constructs would be most important in the hypoxia longevity circuit. Conversely, we hypothesized that candidate neurons within rescues that did not restore a WT-like hypoxia response are less likely to be important (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>; <xref rid="figs2" ref-type="fig">Fig. S2A</xref>). We acknowledge that this analysis strategy is biased toward neurons rescued in a greater proportion of the transgenic strains, which could lead to false negatives. From this analysis, we identified 10 neurons that were rescued in 3-4 of the 6 successful rescue constructs (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>). Five of these neurons (DVB, FLP, M1, RME_LR, and RME_DV) were also present in unsuccessful rescue constructs, so they were not considered for follow-up experiments. Of the remaining five neurons (RIS, AUA, AVC, LUA, and VD_DD), the top candidate was the RIS neuron, because RIS was present in the highest number (4 as shown in <xref rid="fig2" ref-type="fig">Fig. 2B</xref>) of successful rescue constructs.</p>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 2.</label>
<caption><title>s<italic>e</italic>r<italic>-7</italic> expression in each <italic>ser-7</italic> expressing neuron is rescued by at least one construct, and <italic>ser-7</italic> is required for <italic>vhl-1-</italic>mediated longevity.</title>
<p>(<bold>A</bold>) A table showing all <italic>ser-7</italic> expressing candidate neurons, and which constructs in <xref rid="fig2" ref-type="fig">Fig. 2A</xref> restored <italic>ser-7</italic> expression in these neurons. Pink rows indicate rescues that fully restored <italic>vhl-1</italic> mediated <italic>fmo-2</italic> induction, orange rows indicate rescues that partially restored <italic>vhl-1-</italic>mediated <italic>fmo-2</italic> induction, and gray rows signify unsuccessful rescue constructs from the data in panel A. (<bold>B</bold>) Survival curve of WT, and <italic>ser-7(tm1325)</italic> worms on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 259 worms per condition. Significance is from a log-rank test comparing median survival. Cox Regression for an interaction between the effect of <italic>ser-7 (tm1325)</italic> knockout and <italic>vhl-1</italic> RNAi knockdown on lifespan. <italic>p</italic> = 0.003, **. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. Three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To validate whether the RIS neuron is a key signaling cell in hypoxia-mediated longevity, we first genetically ablated the RIS neuron to test its necessity. Our results showed that <italic>vhl-1</italic> RNAi does not extend lifespan of RIS ablated worms, indicating that the RIS neuron is completely required for <italic>vhl-1</italic> knockdown to extend lifespan (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). To test the sufficiency of RIS signaling, we next rescued <italic>ser-7</italic> expression in the RIS neuron in the <italic>ser-7</italic> null background under the <italic>flp-11</italic> promoter. <italic>flp-11</italic> is expressed in the RIS neuron<sup><xref ref-type="bibr" rid="c46">46</xref></sup> and uv1 neuroendocrine cells<sup><xref ref-type="bibr" rid="c47">47</xref></sup> that do not endogenously express <italic>ser-7</italic><sup><xref ref-type="bibr" rid="c45">45</xref></sup>. We first confirmed that <italic>ser-7</italic> knockout worms are partially required for <italic>vhl-1</italic> RNAi to extend lifespan (<xref rid="figs2" ref-type="fig">Fig. S2B</xref>, Cox Regression, <italic>p</italic> = 0.003, **). Significantly, <italic>ser-7</italic> rescue in the RIS neuron (<italic>ser-7; flp-11p::ser-</italic>7) restores the lifespan extension by <italic>vhl-1</italic> RNAi to the same degree as WT worms (<xref rid="fig2" ref-type="fig">Fig. 2D</xref>). These data suggest that <italic>ser-7</italic> expression in the RIS neuron only is sufficient for <italic>vhl-1-</italic>mediated longevity. However, one limitation of this approach is that non-physiological expression of <italic>ser-7</italic> in the uv1 cells could play a role in restoration of a WT-like hypoxic response. Together, these data are consistent with a model where hypoxic conditions stabilize HIF-1 in the ADF neurons, which modify serotonin signaling to the SER-7 receptor on the RIS interneuron.</p>
</sec>
<sec id="s2b">
<title>Tyraminergic signaling from the RIM neuron and the tyramine receptor TYRA-3 are required for <italic>vhl-1</italic> knockdown to extend lifespan</title>
<p>After identifying neuron subtypes involved in serotonin signaling downstream of the hypoxic response, we next set out to identify whether other neurotransmitters act in the pathway. To answer this question, we obtained mutants deficient in the production of each type of neurotransmitter in <italic>C. elegans</italic> (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>) and measured their lifespan on control and <italic>vhl-1</italic> RNAi. Out of the six neurotransmitters we tested, blocking the production of GABA (<italic>unc-25</italic>, <xref rid="fig3" ref-type="fig">Fig. 3B</xref>) or tyramine + octopamine (<italic>tdc-1,</italic> <xref rid="fig3" ref-type="fig">Fig. 3C</xref>) attenuated longevity on <italic>vhl-1</italic> RNAi. The requirement of GABA is consistent with our finding that <italic>ser-7</italic> expression on the GABAergic RIS neuron is also necessary for hypoxic response-mediated longevity (<xref rid="fig2" ref-type="fig">Fig. 2</xref>), connecting the serotonergic and GABAergic components of this circuit.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>GABA and tyramine synthesis are required for the hypoxic response to extend lifespan.</title>
<p>(<bold>A</bold>) Summary table of the necessity of each <italic>C. elegans</italic> neurotransmitter for <italic>vhl-1</italic> RNAi<italic>-</italic>mediated longevity. (<bold>B-E</bold>) Survival curves of WT and <italic>unc-25(e156)</italic> (GABA deficiency) (<bold>B</bold>), <italic>tdc-1(n3419)</italic> (tyramine + octopamine deficiency) (<bold>C</bold>), <italic>tbh-1(n3247)</italic> (octopamine deficiency) (<bold>D</bold>), and RIC ablation (<italic>Ex[tbh-1p::caspase-3(p12)-nz]; Ex[tbh-1p::cz-caspase-3 (p17)]; tbh-1p::GFP</italic>) (<bold>E</bold>) worms on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 310 (<bold>B</bold>), ≥ 201 (<bold>C</bold>), ≥ 258 (<bold>D</bold>), and ≥ 258 (<bold>E</bold>) worms per condition. Significance in panels B-E is from a log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Tyramine (analogous to mammalian adrenaline<sup><xref ref-type="bibr" rid="c48">48</xref></sup>) is synthesized from tyrosine by tyrosine decarboxylase (<italic>tdc-1</italic>) and can be further converted to octopamine (analogous to mammalian noradrenaline) by tyramine β-hydroxylase (<italic>tbh-1</italic>) in <italic>C. elegans</italic><sup><xref ref-type="bibr" rid="c49">49</xref></sup>. Therefore, the <italic>tdc-1</italic> knockout is deficient in both tyramine and octopamine synthesis (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>) and the <italic>tbh-1</italic> knockout (<xref rid="fig3" ref-type="fig">Fig. 3D</xref>) is only deficient in octopamine synthesis. Since worms lacking only octopamine (<italic>tbh-1</italic>, <xref rid="fig3" ref-type="fig">Fig. 3D</xref>) were long-lived on <italic>vhl-1</italic> RNAi but worms lacking both tyramine and octopamine (<italic>tdc-1</italic>, <xref rid="fig3" ref-type="fig">Fig. 3C</xref>) were not, we can conclude that tyramine is required for the hypoxic response to extend lifespan. To further test whether tyramine but not octopamine is involved in this pathway, we generated a strain in which the primary octopamine-producing neuron, RIC<sup><xref ref-type="bibr" rid="c49">49</xref></sup>, is genetically ablated. We found that the RIC neuron is not required for <italic>vhl-1-</italic>mediated longevity (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>), further supporting that tyramine but not octopamine is a key neurotransmitter in the hypoxic response longevity circuit.</p>
<p>In addition to octopamine (<italic>tbh-1,</italic> <xref rid="figs3" ref-type="fig">Fig. S3C</xref>), we also observed that acetylcholine (<italic>unc-17</italic>, <xref rid="figs3" ref-type="fig">Fig. S3A</xref>) and glutamate (<italic>eat-4</italic>, <xref rid="figs3" ref-type="fig">Fig. S3B</xref>) were not required for lifespan extension by <italic>vhl-1</italic> RNAi. Our lifespans of the dopamine synthesis mutant <italic>cat-2</italic> indicated that dopamine is inconsistently required for the hypoxic response to extend lifespan. In three biological replicates, we observed a full requirement, partial requirement, and no requirement for dopamine synthesis in <italic>vhl-1</italic> RNAi-mediated longevity. When analyzed together, the net result suggests that dopamine is partially required for <italic>vhl-1-</italic>mediated longevity (<xref rid="figs3" ref-type="fig">Fig. S3C</xref>, Cox Regression for interaction between genotype and <italic>vhl-1</italic> RNAi, <italic>p &lt;</italic> 0.0001, ****). We did not follow up on dopamine due to the inconsistency. Together, the results from this neurotransmitter screen support the conclusion that in addition to serotonin, both GABA and tyramine play a role in hypoxic response-mediated longevity.</p>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 3.</label>
<caption><title>Acetylcholine, glutamate, and dopamine synthesis are not fully required for <italic>vhl-1</italic> RNAi to extend lifespan.</title>
<p>(<bold>A-C</bold>) Survival curves of WT and <italic>unc-17(e113)</italic> (acetylcholine deficiency) (<bold>A</bold>), <italic>eat-4(ky5)</italic> (glutamate deficiency) (<bold>B</bold>), and <italic>cat-2(n4547)</italic> (dopamine deficiency) (<bold>C</bold>) worms on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 213 (<bold>A</bold>), ≥ 274 (<bold>B</bold>), and ≥ 270 (<bold>C</bold>) worms per condition. (<bold>C</bold>) Cox Regression for an interaction between genotype and <italic>vhl-1</italic> RNAi, p &lt; 0.0001, ****. Significance in all panels is from a log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Nematodes synthesize GABA in 26 of 302 neurons while tyramine is only synthesized in two cells<sup><xref ref-type="bibr" rid="c50">50</xref></sup>. As a result, identifying highly specific components of tyraminergic signaling is more feasible than mapping GABAergic signaling components. Therefore, we sought to determine the tyramine-producing neuron(s) and tyramine receptor(s) that contribute to hypoxic response-mediated longevity. In <italic>C. elegans</italic>, the two canonically tyraminergic cell types (the RIM neuron and the uv1 neuroendocrine cells) express <italic>tdc-1</italic> but not <italic>tbh-1</italic><sup><xref ref-type="bibr" rid="c50">50</xref></sup>. To determine which tyraminergic cell(s) act in the hypoxic response pathway, we expressed <italic>tdc-1</italic> under promoters specific to either RIM or uv1 in a <italic>tdc-1</italic> null background<sup><xref ref-type="bibr" rid="c14">14</xref></sup>. We then measured whether the lifespans of these tyramine rescue strains could be extended by <italic>vhl-1</italic> RNAi. Our results showed that <italic>vhl-1</italic> RNAi extended lifespan in the RIM rescue strain (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>), but not in the uv1 rescue (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). This finding demonstrates that tyramine synthesis in the RIM neuron is sufficient for <italic>vhl-1</italic> RNAi to extend lifespan. Notably, both tyramine rescue constructs lived longer than WT controls (<xref rid="fig4" ref-type="fig">Fig. 4A-B</xref>). This could indicate that altering tyramine signaling modifies lifespan both within and independently of the <italic>vhl-1-</italic>mediated longevity pathway.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>The RIM neuron and the tyramine receptor <italic>tyra-3</italic> act in the hypoxic response-mediated longevity pathway.</title>
<p>(<bold>A-B</bold>) Survival curves of WT, RIM rescue (<italic>tdc-1 (n3419);</italic> Ex[<italic>ocr-4p::tdc-1])</italic> (<bold>A</bold>), and uv1 <italic>tdc-1</italic> rescue (<italic>tdc-1 (n3419);</italic> Ex[<italic>gcy-13p::tdc-1])</italic> (<bold>B</bold>) strains on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 126 (<bold>A</bold>) and <italic>N</italic> ≥ 140 (<bold>B</bold>) worms per condition. (<bold>C</bold>) Survival curves of TU3311(<italic>unc-119p::sid-1)</italic> and <italic>vhl-1(ok161);</italic> TU3311(<italic>unc-119p::sid-1</italic>) worms on empty vector (EV) and <italic>tyra-3</italic> RNAi. <italic>N</italic> ≥ 215 worms per condition. Significance in all panels is from a log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To identify the tyramine receptor(s) necessary in the hypoxic response-mediated longevity pathway, we used RNAi to knockdown each of <italic>C. elegans’</italic> four known tyramine receptors<sup><xref ref-type="bibr" rid="c51">51</xref>–<xref ref-type="bibr" rid="c54">54</xref></sup> (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>). Since tyramine receptors are mostly expressed in neurons, and RNAi uptake into some neurons is less efficient than other cell types, we used a strain with enhanced neuronal RNAi uptake (TU3311, <italic>unc-119p::sid-1</italic>) crossed into <italic>vhl-1</italic> knockout worms. This neural enhanced RNAi uptake strain was not used previously in this work for <italic>vhl-1</italic> RNAi experiments because <italic>vhl-1</italic> RNAi knockdown extends lifespan in WT worms<sup><xref ref-type="bibr" rid="c31">31</xref></sup>.</p>
<p>The generated <italic>vhl-1; unc-119p::sid-1</italic> strain was long-lived compared to the control strain <italic>unc-119p::sid-1</italic> (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>). Successful RNAi knockdown was validated via qPCR (<xref rid="figs4" ref-type="fig">Fig. S4A</xref>). Our lifespan results show that the tyramine receptor <italic>tyra-3</italic> was fully required for <italic>vhl-1-</italic> mediated longevity (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>), but the tyramine receptors <italic>tyra-2</italic> and <italic>ser-2</italic> were not (<xref rid="figs4" ref-type="fig">Fig. S4B-C</xref>). Another tyramine receptor, <italic>Igc-55,</italic> showed a partial requirement for <italic>vhl-1</italic>-mediated longevity (<xref rid="figs4" ref-type="fig">Fig. S4D</xref>). Although there was a lifespan extension by <italic>vhl-1</italic> on <italic>Igc-55</italic> RNAi (<xref rid="figs4" ref-type="fig">Fig. S4D</xref>), we did observe a significant interaction between <italic>lgc-55</italic> knockdown and genotype on lifespan (Cox Regression, <italic>p</italic> &lt; 0.0001, ****), indicating a partial requirement. In summary, these data indicate that tyramine signaling from the RIM neuron to the TYRA-3 receptor is required for hypoxic response-mediated longevity, while the LGC-55 receptor may play a partial role. Interestingly, TYRA-3 is highly expressed on the low oxygen/high carbon dioxide-sensing BAG neuron as well as in the intestine<sup><xref ref-type="bibr" rid="c45">45</xref>,<xref ref-type="bibr" rid="c55">55</xref></sup>, the site of <italic>fmo-2</italic> induction during hypoxia<sup><xref ref-type="bibr" rid="c31">31</xref></sup>.</p>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 4.</label>
<caption><title>t<italic>y</italic>ra<italic>-2</italic> and <italic>ser-2</italic> are not necessary for <italic>vhl-1-</italic>mediated longevity, while <italic>lgc-55</italic> is partially required.</title>
<p>(<bold>A</bold>) Gene expression of <italic>tyra-3, tyra-2, ser-2,</italic> and <italic>lgc-55</italic> in TU3311(<italic>unc-119p::sid-1)</italic> worms raised on RNAi targeting each gene compared to control worms raised on empty vector (EV) RNAi for two generations. <italic>N</italic> ≥ 300 worms per replicate, or 900 worms per condition. The top of the bar represents the mean of the population and error bars indicate standard error of the mean (SEM). (<bold>B-D</bold>) Survival curves of TU3311(<italic>unc-119p::sid-1)</italic> and <italic>vhl-1(ok161);</italic> TU3311(<italic>unc-119p::sid-1</italic>) worms on empty vector (EV) and <italic>tyra-2</italic> (<bold>B</bold>), <italic>ser-2</italic> (<bold>C</bold>), or <italic>lgc-55</italic> (<bold>D</bold>) RNAi. Cox Regression for an interaction between <italic>lgc-55</italic> knockdown and <italic>vhl-1</italic> knockout on lifespan in the TU3311background strain. <italic>p</italic> &lt; 0.0001, ****. <italic>N</italic> ≥ 215 worms per condition. Significance is from a log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>Oxygen and carbon dioxide sensing neurons act downstream of serotonin signaling</title>
<p>Given that <italic>tyra-3</italic> is highly expressed in the canonical low-oxygen sensing neuron BAG<sup><xref ref-type="bibr" rid="c45">45</xref></sup>, we next explored whether neurons responsible for sensing high- and low-oxygen conditions are essential for hypoxic response-mediated longevity. <italic>C. elegans</italic> have four oxygen sensory neurons: the URX, PQR, and AQR neurons detect high levels of oxygen<sup><xref ref-type="bibr" rid="c55">55</xref></sup>, the BAG neuron responds to low levels of oxygen<sup><xref ref-type="bibr" rid="c56">56</xref></sup> and high levels of carbon dioxide<sup><xref ref-type="bibr" rid="c57">57</xref></sup> (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). We hypothesized that these oxygen sensing cells may perceive hypoxic conditions and help initiate the hypoxic response. Alternatively, these oxygen sensing neurons could modify behavior in response to hypoxia but not play a role in longevity. We found that <italic>vhl-1</italic> knockdown was unable to extend lifespan when we genetically ablated the three high-oxygen sensing neurons (URX, AQR, PQR, <xref rid="fig5" ref-type="fig">Fig. 5B</xref>). Interestingly, the low O<sub>2</sub>/high CO<sub>2</sub> responsive BAG neurons were also required for <italic>vhl-1-</italic>mediated longevity (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>). We next crossed the URX/AQR/PQR ablation worms or BAG ablation worms into <italic>C. elegans</italic> with HIF-1 stabilized in the ADF neurons. Ablation of either the URX/PQR/AQR or the BAG neurons abrogated lifespan extension in the ADF HIF-1 stabilized worms. This suggests that oxygen sensing neurons act downstream of ADF HIF-1 stabilization in this pathway (<xref rid="fig5" ref-type="fig">Fig. 5D-E</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5:</label>
<caption><title>High- and low-oxygen sensing neurons are important for hypoxic response-mediated longevity.</title>
<p>(<bold>A</bold>) Diagram of oxygen sensing neurons in <italic>C. elegans</italic>. (<bold>B</bold>) Survival curves of WT and URX/PQR/AQR ablated worms (<italic>qaIs2241 [gcy-36::egl-1 + gcy-35::GFP + lin-15(+)</italic>]) on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 279 worms per condition. (<bold>C</bold>) Survival curves of WT and BAG ablated worms (<italic>Ex[gcy-31p::caspase-3(p12)-nz]; Ex[gcy-31p::cz-caspase-3 (p17)]; gcy-31p::GFP</italic>) on empty vector (EV) and <italic>vhl-1</italic> RNAi. <italic>N</italic> ≥ 188 worms per condition. (<bold>D</bold>) Survival curves of WT, <italic>hif-1(ia4);</italic> ADF-HIF-1S, URX/PQR/AQR (<italic>qaIs2241 [gcy-36::egl-1 + gcy-35::GFP + lin-15(+)</italic>]) ablation, and URX/PQR/AQR (<italic>qaIs2241 [gcy-36::egl-1 + gcy-35::GFP + lin-15(+)</italic>]) ablation; <italic>hif-1(ia4);</italic> ADF-HIF-1S worms. <italic>N</italic> ≥ 150 worms per condition. (<bold>E</bold>) Survival curves of WT, <italic>hif-1(ia4);</italic> ADF-HIF-1S, BAG (<italic>Ex[gcy-31p::caspase-3(p12)-nz]; Ex[gcy-31p::cz-caspase-3 (p17)]; gcy-31p::GFP</italic>) ablation, and BAG (<italic>Ex[gcy-31p::caspase-3(p12)-nz]; Ex[gcy-31p::cz-caspase-3 (p17)]; gcy-31p::GFP</italic>) ablation; <italic>hif-1(ia4);</italic> ADF-HIF-1S worms. <italic>N</italic> ≥ 186 worms per condition. Significance in all panels is from a log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>The neuropeptide NLP-17 and its receptors contribute to <italic>vhl-1-</italic>mediated longevity</title>
<p>After identifying neurons, neurotransmitters, and neuroreceptors acting in the hypoxic response longevity circuit, we wondered how this neural circuit ultimately propagates information about hypoxic conditions to the intestine and induces the pro-longevity gene <italic>fmo-2</italic>. The <italic>C. elegans</italic> nervous system does not directly innervate the intestine. Instead, neurosignaling molecules bind to receptors on peripheral tissues through packaging in dense-core vesicles and subsequent release into and diffusion through pseudocoelomic fluid<sup><xref ref-type="bibr" rid="c58">58</xref>,<xref ref-type="bibr" rid="c59">59</xref></sup>. These dense-core vesicles are packaged with a wide variety of neuropeptide signals, although there is also evidence that bioaminergic neurotransmitters like serotonin, dopamine, and adrenaline/noradrenaline can also signal through this dense-core vesicle mechanism<sup><xref ref-type="bibr" rid="c59">59</xref>–<xref ref-type="bibr" rid="c61">61</xref></sup>.</p>
<p>We first tested if inducing the hypoxic response through <italic>vhl-1</italic> RNAi extends lifespan in a mutant strain lacking the dense-core vesicle packaging gene <italic>unc-31</italic>. We observed that <italic>unc-31</italic> was required for <italic>vhl-1</italic> knockdown to extend lifespan (<xref rid="fig6" ref-type="fig">Fig. 6A</xref>). To examine whether neuropeptide signals carried by dense-core vesicles are involved, we knocked down two neuropeptide processing enzymes—<italic>egl-3</italic> and <italic>egl-21</italic><sup><xref ref-type="bibr" rid="c62">62</xref></sup>. Successful knockdown was validated with qPCR (<xref rid="figs5" ref-type="fig">Fig. S5A</xref>). Interestingly, <italic>egl-21</italic> but not <italic>egl-3</italic> was required for <italic>vhl-1-</italic> mediated longevity (<xref rid="fig6" ref-type="fig">Fig. 6B-C</xref>). This could be because <italic>egl-21</italic> is the only enzyme known to perform the carboxypeptidase E cleavage step of neuropeptide processing<sup><xref ref-type="bibr" rid="c63">63</xref></sup>, while there are four known proprotein convertases with similar function to <italic>egl-3</italic><sup><xref ref-type="bibr" rid="c62">62</xref>,<xref ref-type="bibr" rid="c64">64</xref></sup>.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>The neuropeptide <italic>nlp-17</italic> and its receptors <italic>npr-37</italic> and <italic>npr-43</italic> are required for hypoxic response-mediated longevity.</title>
<p>(<bold>A</bold>) Survival curves of <italic>unc-31(e169)</italic> and WT worms on empty vector (EV) and vhl-1 RNAi. <italic>N ≥</italic> 242 worms per condition. (<bold>B-C</bold>) Survival curves of TU3311 (<italic>unc-119p::sid-1)</italic> and <italic>vhl-1(ok161);</italic> TU3311 (<italic>unc-119p::sid-1)</italic> worms on empty vector (EV) and <italic>egl-3</italic> (<bold>B</bold>) or <italic>egl-21</italic> (<bold>C</bold>) RNAi. <italic>N ≥</italic> 209 worms (<bold>B</bold>) and <italic>N ≥</italic> 185 worms (<bold>C</bold>) per condition. (<bold>D</bold>) Summary table of two sets of neuropeptide ligands/receptors that blunted <italic>vhl-1-</italic> mediated lifespan. (<bold>E-G</bold>) Survival curves of TU3311 (<italic>unc-119p::sid-1)</italic> and <italic>vhl-1(ok161);</italic> TU3311 (<italic>unc-119p::sid-1)</italic> worms on empty vector (EV) and <italic>npr-37</italic> (<bold>E</bold>), <italic>npr-43</italic> (<bold>F</bold>), or <italic>nlp-17</italic> (<bold>G</bold>) RNAi. <italic>N ≥</italic> 288 worms (<bold>E</bold>), <italic>N ≥</italic> 309 worms (<bold>F</bold>), and <italic>N ≥</italic> 309 worms (<bold>G</bold>) per condition. Significance in panels A-C and E-G are from log-rank test comparing median survival. Cox Regression for a significant interaction between <italic>npr-43</italic> knockdown and <italic>vhl-1</italic> knockout on lifespan, <italic>p</italic> &lt;0.01, **. Cox regression for a significant interaction between <italic>nlp-17</italic> knockdown and <italic>vhl-1</italic> knockout on lifespan, p &lt; 0.05, *. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, three replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We next tested a group of 6 genes corresponding to neuropeptide/receptor binding pairs that blunted hypoxic response-mediated <italic>fmo-2</italic> induction (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>). These genes, along with their corresponding receptors, were targeted for RNAi and tested for lifespan in TU3311 (<italic>unc-119p::sid-1</italic>) and TU3311 (<italic>unc-119p::sid-1</italic>); <italic>vhl-1 (ok161)</italic> strains. We found that the <italic>npr-3</italic> receptor and it’s ligands, <italic>flp-15</italic> and <italic>flp-21</italic> were not required for <italic>vhl-1</italic>-mediated longevity. (<xref rid="figs5" ref-type="fig">Fig. S5B-D</xref>). However, knocking down the neuropeptide <italic>nlp-17</italic> partially blocked <italic>vhl-1</italic>-mediated longevity (<xref rid="fig6" ref-type="fig">Fig. 6E</xref>, Cox regression <italic>p &lt; 0.05</italic>). Consistently, knocking down <italic>nlp-17’</italic>s receptors also completely (<italic>npr-37</italic>, <xref rid="fig6" ref-type="fig">Fig. 6F</xref>) or partially (<italic>npr-43</italic>, <xref rid="fig6" ref-type="fig">Fig. 6G</xref>, Cox regression <italic>p &lt; 0.001</italic>) blocked <italic>vhl-1-</italic>mediated longevity. Successful knockdown of <italic>npr-37</italic> and <italic>npr-43</italic> was validated with qPCR (<xref rid="figs5" ref-type="fig">Fig. S5A</xref>). The <italic>nlp-17</italic> ligand result was validated using a genetic knockout (<italic>nlp-17 (ok3461)</italic>), which completely prevented <italic>vhl-1</italic> knockdown from extending lifespan (<xref rid="figs5" ref-type="fig">Fig. S5E</xref>). Together, these data suggest a role for NLP-17 signaling in hypoxic response-mediated longevity.</p>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 5.</label>
<caption><title>qPCR validation of RNAi hits from Figure 5, and neuropeptide screen hits that did not validate.</title>
<p>(<bold>A-B</bold>) Gene expression of (<bold>A</bold>) <italic>egl-3, egl-21, npr-37,</italic> and <italic>npr-43</italic> in TU3311 (<italic>unc-119p::sid-1)</italic> worms raised on RNAi targeting each gene compared to control worms raised on empty vector (EV) RNAi for two generations. <italic>N</italic> ≥ 300 worms per replicate, or 900 worms per condition. The top of the bar represents the mean and error bars represent SEM. (<bold>B-D</bold>) Survival curves of TU3311 (<italic>unc-119p::sid-1)</italic> and <italic>vhl-1(ok161);</italic> TU3311 (<italic>unc-119p::sid-1)</italic> worms on empty vector (EV) and <italic>npr-3</italic> (<bold>B</bold>), <italic>flp-15</italic> (<bold>C</bold>), or <italic>flp-21</italic> (<bold>D</bold>) RNAi. <italic>N ≥</italic> 191 worms (<bold>B</bold>), <italic>N ≥</italic> 181 worms (<bold>C</bold>), and <italic>N ≥</italic> 183 worms (<bold>D</bold>) per condition. (<bold>E</bold>) Survival curves of <italic>nlp-17(ok3461)</italic> on empty vector (EV) or vhl-1 RNAi. <italic>N ≥</italic> 275 worms per condition. Significance in panels B-E are from log-rank test comparing median survival. NS. = <italic>p &gt;</italic> 0.05, * = <italic>p</italic> &lt; 0.05, ** = <italic>p</italic> &lt; 0.01, *** = <italic>p</italic> &lt; 0.001, and **** = <italic>p</italic> &lt; 0.0001. In all panels, 2-3 replicates were plotted together, and all statistics include a Bonferroni correction for multiple comparisons.</p></caption>
<graphic xlink:href="652087v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Taken together, these results support a model in which HIF-1 stabilization in the ADF serotonergic neurons leads to modified serotonin signaling from the ADF to the SER-7 expressing and GABA-producing RIS neuron (<xref rid="fig7" ref-type="fig">Fig. 7</xref>). Oxygen sensing neurons act downstream of HIF-1 stabilization in the ADF neuron in the hypoxic response longevity circuit. Tyramine produced by the RIM neuron and neuropeptide (NLP-17) signaling are also required for the hypoxic response to extend lifespan, although it remains unclear whether these signals act upstream, downstream, or in parallel to the serotonergic and GABAergic components in this pathway.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Working model of the hypoxia-mediated longevity pathway.</title></caption>
<graphic xlink:href="652087v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In this study, we interrogated a complex signaling pathway through which genetic induction of the hypoxic response extends lifespan in <italic>C. elegans</italic>. Within this pathway, we demonstrate that: 1) stabilization of HIF-1 in the ADF serotonergic neurons modifies signaling to the SER-7 receptor on the GABAergic and neuropeptidergic RIS neuron (<xref rid="fig1" ref-type="fig">Fig. 1</xref>-<xref rid="fig2" ref-type="fig">2</xref>); 2) tyraminergic signaling through the RIM neuron and the TYRA-3 receptor (<xref rid="fig3" ref-type="fig">Fig. 3</xref>-<xref rid="fig4" ref-type="fig">4</xref>) are required for hypoxic response-mediated longevity; 3) oxygen and carbon-dioxide sensory neurons act downstream of HIF-1 stabilization and serotonergic ADF neurons to extend lifespan (<xref rid="fig5" ref-type="fig">Fig. 5</xref>); and 4) in addition to neurotransmitter signals, the neuropeptide NLP-17 and its receptors NPR-37 and NPR-43 are required for the hypoxic response to extend lifespan (<xref rid="fig6" ref-type="fig">Fig. 6</xref>). Ultimately, these neural signals converge on the intestine, to activate FMO-2 and extend lifespan (working model summarized in <xref rid="fig7" ref-type="fig">Fig. 7</xref>).</p>
<p>The hypoxic response is highly conserved across species, highlighting the potential relevance of this pathway in other organisms, including humans. In nematodes, activating the hypoxic response promotes health and longevity. However, the physiological changes induced by the hypoxic response are broad and involve adaptations that can drive tumorigenesis in mammals. Therefore, a mechanistic understanding of the individual cells, signals, and circuits that mediate the beneficial effects of hypoxia is essential. In this work, the discovery that HIF-1 stabilization in the ADF neurons extends lifespan by 26% demonstrates the potential for targeted manipulations within this pathway to have large effects on lifespan. Additionally, our data identify a previously unknown role for tyramine/adrenaline in the hypoxic response as well as establish NLP-17, a neuropeptide with no previous known function, as a signal in <italic>vhl-1-</italic>mediated longevity. This work also demonstrates that the oxygen sensing AQR, PQR, URX, and BAG neurons act downstream of the serotonergic ADF neuron in the hypoxic response, indicating an interaction between internal and external oxygen sensing mechanisms in longevity. Together, the mapping of these cells, signaling molecules, and receptors in the hypoxic response lays the foundation to discover druggable targets that selectively modulate aging in humans without negative side effects.</p>
<p>Other studies in <italic>C. elegans</italic> have also identified neural networks involving the hypoxic response. For example, previous work found a role for HIF-1 in hypoxia-mediated behaviors, such as food-dependent hyperoxia (excessive oxygen) avoidance<sup><xref ref-type="bibr" rid="c65">65</xref></sup>. Hyperoxia avoidance requires <italic>hif-1</italic> expression both in the neurons and the tyraminergic uv1 neuroendocrine cells. Interestingly, serotonin signaling from the ADF neuron is also required for WT-like hyperoxia avoidance<sup><xref ref-type="bibr" rid="c65">65</xref></sup>. While this HIF-1-mediated behavioral circuit has parallels with the HIF-1-mediated longevity circuit interrogated in this work, these pathways do diverge: the key tyraminergic cell type implicated in hyperoxia avoidance is the uv1 gonadal neuroendocrine cells, while the RIM tyraminergic neurons played a role in longevity (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). Together, the partial overlap between this behavioral and longevity circuit implies that modifying neural signaling to induce the hypoxic response and extend lifespan may also alter behavioral phenotypes. Future research in this area should interrogate exactly where these and any other HIF-1-mediated circuits overlap and diverge.</p>
<p>While this study identifies many neural signals required for <italic>vhl-1</italic> knockdown or knockout to extend lifespan, one key limitation of this work is the potential differences between genetic and environmental methods of inducing the hypoxic response. While <italic>vhl-1</italic> knockdown or knockout leads to HIF-1 stabilization by blocking its proteasomal degradation, it also results in hydroxylated but stable HIF-1. This contrasts with environmental hypoxia, in which HIF-1 remains stable because it cannot be hydroxylated. While HIF-1 is stabilized and localized to the nucleus in both cases, there are differences in transcriptional outcomes between stable hydroxylated and unhydroxylated states<sup><xref ref-type="bibr" rid="c66">66</xref>,<xref ref-type="bibr" rid="c67">67</xref></sup>.</p>
<p>Additionally, we did not explore the effects of alternative genetic activators of the hypoxic response such as PHD/EGL mutants, which may provide further insight into how different manipulations of the hypoxic response impact longevity.</p>
<p>The circuit-mapping approaches employed in this work are also impacted by limitations in cell-specific genetic modifications and in the use of RNAi knockdown. For example, cell-specific rescue constructs can sometimes lead to unintended rescues in other cell types due to cell-nonautonomous signaling. Because all serotonin-producing neurons also express the serotonin reuptake transporter <italic>mod-5</italic>, serotonin produced by one cell in our rescue strains could be taken up by other serotonin-producing neurons, leading to unintended signaling effects. This may also be true of the uv1 and RIM tyraminergic rescue strains, although little is known about tyramine reuptake in <italic>C. elegans</italic>.</p>
<p>Additionally, although RNAi experiments were validated using sequence confirmation and qPCR, not all RNAi hits were corroborated with genetic knockouts. This leaves open the possibility that RNAi-induced knockdown effects differ from complete genetic ablation, or that production of a given RNAi may modify bacterial metabolism in a way that indirectly modifies the hypoxic response in <italic>C. elegans</italic>. Finally, while the use of RNAi knockdown and genetic knockouts establishes the necessity of many signals within the hypoxia-mediated longevity circuit, the exact directionality of these signals remains unclear. It is possible that increased, decreased, or pulsatile changes in signaling through these bioamines and neuropeptides are required for the hypoxic response to extend lifespan. Future work in this area could use tools to measure or modify neuronal activity, such as calcium imaging or optogenetics, to begin answering these questions.</p>
<p>While many individual neurosignaling components are essential for the hypoxic response to extend lifespan, their epistasis is unclear. Future work in this area should focus on manipulating various components of this network in a manner that we would expect to mimic hypoxia and extend lifespan. This will allow us to narrow down which signals are necessary only to adapt to hypoxia, and which are sufficient to extend lifespan in a normoxic environment. One notable target for further exploration is the SER-7 expressing RIS neuron, which plays a role in sleep<sup><xref ref-type="bibr" rid="c68">68</xref></sup> and stress resistance<sup><xref ref-type="bibr" rid="c69">69</xref></sup>. Moreover, optogenetically increasing RIS activity can extend lifespan under normoxic conditions<sup><xref ref-type="bibr" rid="c70">70</xref></sup>.</p>
<p>While our understanding of this circuit is still incomplete, our findings point to several promising signaling components that could be targeted for longevity interventions. Manipulating serotonin and tyramine/adrenaline signaling pathways may offer strategies for extending lifespan, with minimal pleiotropic effects if precisely controlled. These neural targets have great potential for longevity therapeutics due to 1) the small number of neurons that can control aging-related pathways in the entire organism; 2) the availability of FDA-approved pharmaceuticals that target individual bioaminergic transporters and receptors<sup><xref ref-type="bibr" rid="c71">71</xref>–<xref ref-type="bibr" rid="c73">73</xref></sup>; and 3) the high conservation of neurotransmitter biology between invertebrates and mammals<sup><xref ref-type="bibr" rid="c50">50</xref>,<xref ref-type="bibr" rid="c62">62</xref>,<xref ref-type="bibr" rid="c74">74</xref></sup>. Further research into how these pathways can be modulated in a targeted manner could spur development of interventions that promote healthy aging and delay the onset of age-related diseases.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Strains and Growth Conditions</title>
<p><italic>C. elegans</italic> were cultured according to established protocols<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. In brief, worms were grown at 20 °C on standard solid nematode growth media (NGM). Throughout their lifespan, the worms were fed <italic>E. coli</italic> OP50, except during RNA interference (RNAi) experiments, where <italic>E. coli</italic> HT115 was used to deliver double-stranded RNA. Transfers of worms were carried out using a platinum wire, unless stated otherwise. The RNAi strains employed are listed in Supplementary Table 1, while the strains used in the experiments are provided in Supplementary Table 2. Genotypes were verified through PCR, and RNAi imaging results were confirmed by sequencing and quantitative PCR (qPCR) before proceeding with the experiments.</p>
</sec>
<sec id="s4b">
<title>Generating transgenic strains</title>
<sec id="s4b1">
<title>Neuron-specific stabilized HIF-1 strains</title>
<p>We used the following promoters to drive cDNA of HIF-1 (P621A)::SL2::GFP in three serotonergic neuronal populations: ADF neurons (<italic>srh-142p::</italic> HIF-1 (P621A)), NSM neurons (<italic>ceh-2p::</italic> HIF-1 (P621A)), HSN neurons (<italic>ham-2p::</italic> HIF-1 (P621A)). All plasmids were verified via restriction digest and sanger sequencing, and ApE files are available upon request.</p>
<p>Plasmids were microinjected to <italic>hif-1(ia4)</italic> KO strain by Suny Biotech using the co-injection marker <italic>myo-2p</italic>::GFP and 2-3 transgenic lines were tested in each experiment.</p>
</sec>
<sec id="s4b2">
<title>Neuron-specific <italic>tph-1</italic> rescues</title>
<p>The pKA805[<italic>srh-142p</italic>::TPH-1] and pKA807[<italic>ceh-2p::</italic>TPH-1] constructs were generously provided by Dr. Kaveh Ashrafi. These constructs were injected at ∼50 ng/µL) with fluorescent co-injection marker <italic>myo-2p</italic>::mNeonGreen (15 ng/µL) or <italic>sur-5p</italic>::<italic>sur-5::</italic>NLSGFP (20 ng/µL) and junk DNA (up to 100 ng/µL) into gonads of day 1 gravid adult hermaphrodites. Standard protocols were followed to isolate and obtain stable over-expression mutants<sup><xref ref-type="bibr" rid="c75">75</xref></sup>.</p>
</sec>
<sec id="s4b3">
<title><italic>ser-7</italic> rescue strains</title>
<p>Plasmid construction and microinjection was conducted by Suny Biotech to generate all <italic>ser-7</italic> rescue constructs. In designing the plasmids, we used the following promoters to drive cDNA of SER-7::SL2::GFP in different neuronal populations: full rescue (<italic>ser-7p::ser-7)</italic>, interneuron rescue (<italic>glr-1p::ser-7)</italic>, bioaminergic neuron rescue (<italic>cat-1p::ser-7)</italic>, glutamatergic neuron rescue (<italic>eat-4p::ser-7</italic>), GABAergic neuron rescue (<italic>unc-47p::ser-7</italic>), GABAergic motor neuron rescue(<italic>unc-25p::ser-7</italic>), sensory neuron rescue (<italic>osm-6p::ser-7</italic>), cholinergic motor neuron rescue(<italic>acr-2p::ser-7</italic>), cholinergic neuron rescue (<italic>unc-17p::ser-7</italic>), M3 &amp; M4 neuron rescue (<italic>ceh-28p::ser-7</italic>), and intestinal rescue (<italic>vha-6p::ser-7</italic>). All plasmids were verified via restriction digest and sanger sequencing, and ApE files are available upon request. Plasmids were microinjected by Suny Biotech using the co-injection marker <italic>myo-2p::</italic>GFP and 2-3 transgenic lines were tested in each experiment.</p>
</sec>
<sec id="s4b4">
<title>RIS, RIC, and BAG neuronal ablation strains</title>
<p>For RIS neuronal ablation strains, we purchased donor plasmid <italic>mec-18p</italic>::caspase-3 (p12)::nz [TU#813] (Plasmid #16082) and <italic>mec-18p</italic> cz::caspase-3 (p17) [TU#814] from Addgene (Plasmid #16083), and used Gibson cloning (NEB) to replace <italic>mec-18p</italic> with <italic>srsx-18p</italic>. Three constructs <italic>srsx-18p</italic>::caspase-3(p12)::nz, <italic>srsx-18p</italic>::cz::caspase-3(p17), and <italic>srsx-18p</italic>::GFP were co-injected with fluorescent co-injection marker <italic>myo-3p</italic>::GFP (20 ng/µL) into the wild-type N2 strain to generate RIS genetic ablation strains. Similarly, for RIC ablation strain, <italic>tbh-1p</italic> was constructed into TU#813 and TU#814 to replace <italic>mec-18p</italic>. Three constructs <italic>tbh-1p</italic>::caspase-3(p12)::nz, <italic>tbh-1p</italic>::cz::caspase-3(p17), and <italic>tbh-1p</italic>::GFP were co-injected with fluorescent co-injection marker <italic>myo-3p</italic>::GFP (20 ng/µL) into the wild-type N2 strain to generate RIC genetic ablation strains. For BAG ablation strain, <italic>gcy-31p</italic> was constructed into TU#813 and TU#814 to replace <italic>mec-18p</italic>. Three constructs <italic>gcy-31p</italic>::caspase-3(p12)::nz, <italic>gcy-31p</italic>::cz::caspase-3(p17), and <italic>gcy-31p</italic>::GFP were co-injected with fluorescent co-injection marker <italic>myo-3p</italic>::GFP (20 ng/µL) into the wild-type N2 strain to generate BAG genetic ablation strains. All plasmids were verified via restriction digest and sanger sequencing. ApE files available upon request. Plasmid construction and microinjection was conducted by Suny Biotech.</p>
</sec>
<sec id="s4b5">
<title>RIM and uv1 <italic>tdc-1</italic> rescue strains</title>
<p>Plasmid construction and microinjection was conducted by Suny Biotech to generate both <italic>tdc-1</italic> rescue constructs. In designing the plasmids, we used the <italic>ocr-4</italic> promoter to drive cDNA of TDC-1::SL2::GFP in the uv1 neuroendocrine cells. To express cDNA of TDC-1::SL2::GFP in the RIML neuron, we used the <italic>gcy-13</italic> promoter. All plasmids were verified via restriction digest and sanger sequencing, and ApE files are available upon request.</p>
<p>Plasmids were microinjected by Suny Biotech using the co-injection marker <italic>myo-2</italic>p::GFP.</p>
</sec>
</sec>
<sec id="s4c">
<title>RNAi Knockdown</title>
<p>For all RNAi knockdowns, worms were exposed to the RNAi treatment for two generations to achieve optimal knockdown. All RNAi clones were sourced from the Vidal RNAi library. Each RNAi clone was sequence-verified.</p>
</sec>
<sec id="s4d">
<title>Quantitative PCR</title>
<p>For RNAi validation experiments, RNA was isolated from day 1 adult worms that had been grown on RNAi for two generations. For measuring <italic>fmo-2</italic> induction in the <italic>hif-1(ia4);</italic> ADF::HIF-1S strain, worms were grown on OP50, synchronized, and collected at day 1 of adulthood. RNA extraction was performed using the Direct-zol RNA Miniprep Kit (Zymo), and cDNA synthesis was carried out with the Biorad iScript cDNA Synthesis Kit. Gene expression was assessed using the SYBR Green quantitative RT-PCR (qRT-PCR) system (BioRad), with mRNA levels normalized to the housekeeping genes cdc-42 and Y45FD10.4. Primers for RNAi validation were designed to target the 3’ UTR of each gene to avoid amplification of the bacterially produced RNAi. Gene expression was quantified using standard curves.</p>
</sec>
<sec id="s4e">
<title>Lifespan Measurements</title>
<p>Lifespan assays were conducted following previously described protocols<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. Briefly, 10-15 gravid adults were transferred to NGM plates for a three-hour timed egg lay, after which they were removed. Once the progeny reached day 1 of adulthood, 60-80 worms were placed on NGM plates containing 33 µL of 150 mM fluorodeoxyuridine (FUdR) and 100 µL of 50 mg/mL ampicillin per 100 mL of NGM. FUdR inhibits progeny development, while ampicillin prevents bacterial contamination. NGM + FUdR + Ampicillin plates were seeded with concentrated bacteria (5x for OP50-fed lifespan assays). At least two plates per strain and condition were used for each lifespan replicate. Worms were considered dead when they failed to respond to a gentle touch with a platinum wire under a dissection microscope. Lifespan data were recorded at least three times a week until all worms were dead. To prevent escape, a barrier of 75 µL of 100 mM palmitic acid (Sigma-Aldrich) dissolved in 100% ethanol was applied along the edges of each lifespan plate. Data were analyzed using R version 4.3.1 and visualized in Adobe Illustrator 2022.</p>
</sec>
<sec id="s4f">
<title>RNAi Lifespans</title>
<p>RNAi lifespan assays were performed similarly to standard lifespan assays, with modifications to the initial timed egg lay (TEL) procedure and food concentrations. To ensure maximal RNAi knockdown, worms were first TEL’ed for 3 hours on RNAi plates. The progeny from this TEL were left on RNAi plates to develop into gravid adults and then used for a second TEL under the same RNAi conditions. Progeny from the second-generation TEL were then used for the lifespan assay. RNAi bacteria (HT115) are ampicillin-resistant and can grow slowly on AMP-containing lifespan plates. To maintain consistent bacterial availability throughout the lifespan assay, RNAi plates were seeded with bacteria at 2x concentration, starting from an optical density (OD<sub>600</sub>) of 3.0.</p>
</sec>
<sec id="s4g">
<title>Fluorescent Slide Microscopy</title>
<p>Fluorescent images for this study were captured using a Leica M165F fluorescent microscope, controlled by Leica Application Suite X (LASX) software. A minimum of 15 worms per condition were imaged at a magnification of at least 70x. For image quantification, individual worms were carefully separated to ensure they did not touch. Custom R code<sup><xref ref-type="bibr" rid="c76">76</xref></sup> was then used to create a pixel mask of each worm from the brightfield image and measure the fluorescent intensity of that region in the corresponding fluorescent image. The background fluorescence was subtracted from the mean fluorescence values. Data were analyzed using R version 4.3.1 and visualized in Adobe Illustrator 2022.</p>
</sec>
<sec id="s4h">
<title>Statistical Analysis</title>
<p>The height of all bar plots represents the mean value for each condition, with error bars indicating the standard error of the mean (SEM). For comparisons involving more than two conditions, one-way ANOVA followed by post-hoc Tukey HSD tests (2-tailed, unpaired) were used to assess interactions between variables and determine statistical differences between conditions. Significance levels are indicated as *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, and ****p &lt; 0.0001. For lifespan assays, statistical comparisons of survivorship curves were performed using the survfit survival analysis function in R. The log-rank test was used to compare two survival curves. To assess interactions across multiple experimental variables and for comparisons involving more than two survival curves, a Cox regression analysis was conducted using the survivalMPL package in R. For experiments with multiple biological replicates, p-values were adjusted using the Bonferroni correction. Exact sample sizes (Ns) for each experiment are provided in the source data files, and minimum sample sizes for each plot are specified in the figure legends.</p>
</sec>
</sec>

</body>
<back>
<sec id="suppd1e2920" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="tables1">
<label>Supplementary Table 1.</label>
<caption><title>RNAi.</title></caption>
<media xlink:href="supplements/652087_file02.xlsx"/>
</supplementary-material>
<supplementary-material id="tables2">
<label>Supplementary Table 2.</label>
<caption><title>Strains.</title></caption>
<media xlink:href="supplements/652087_file03.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burch</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Augustine</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Frieden</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Hadley</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Howcroft</surname>, <given-names>T.K.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Khalsa</surname>, <given-names>P.S.</given-names></string-name>, <string-name><surname>Kohanski</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.L.</given-names></string-name>, <string-name><surname>Macchiarini</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Advances in geroscience: impact on healthspan and chronic disease</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <volume>69</volume> <issue><italic>Suppl 1</italic></issue>, <fpage>S1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/glu041</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaeberlein</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Longevity and aging</article-title>. <source>F1000Prime Reports</source> <volume>5</volume>. <pub-id pub-id-type="doi">10.12703/P5-5</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kirkland</surname>, <given-names>J.L.</given-names></string-name>, and <string-name><surname>Peterson</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Healthspan, translation, and new outcomes for animal studies of aging</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <volume>64</volume>, <fpage>209</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/gln063</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fontana</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Partridge</surname>, <given-names>L</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Promoting health and longevity through diet: from model organisms to humans</article-title>. <source>Cell</source> <volume>161</volume>, <fpage>106</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.02.020</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Conti</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Considerations on temperature, longevity and aging</article-title>. <source>Cell Mol Life Sci</source> <volume>65</volume>, <fpage>1626</fpage>–<lpage>1630</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-7536-1</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shao</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zhai</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Powell-Coffman</surname>, <given-names>J.A</given-names></string-name></person-group>. (<year>2009</year>). <article-title>The HIF-1 hypoxia-inducible factor modulates lifespan in C. elegans</article-title>. <source>PLoS One</source> <volume>4</volume>, <fpage>e6348</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0006348</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stewart</surname>, <given-names>T.M.</given-names></string-name>, <string-name><surname>Bhapkar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Das</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Galan</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>C.K.</given-names></string-name>, <string-name><surname>McAdams</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Pieper</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Redman</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Roberts</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Stein</surname>, <given-names>R.I.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 (CALERIE Phase 2) screening and recruitment: methods and results</article-title>. <source>Contemp Clin Trials</source> <volume>34</volume>, <fpage>10</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cct.2012.08.011</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Calabrese</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>Dhawan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kapoor</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Iavicoli</surname>, <given-names>I.</given-names></string-name>, and <string-name><surname>Calabrese</surname>, <given-names>V</given-names></string-name></person-group>. (<year>2015</year>). <article-title>What is hormesis and its relevance to healthy aging and longevity?</article-title> <source>Biogerontology</source> <volume>16</volume>, <fpage>693</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-015-9601-0</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rattan</surname>, <given-names>I.S.S</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Hormesis in aging</article-title>. <source>Ageing Research Reviews</source> <volume>7</volume>, <fpage>63</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2007.03.002</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Dou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Li</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Aging and aging-related diseases: from molecular mechanisms to interventions and treatments</article-title>. <source>Signal Transduction and Targeted Therapy</source> <volume>7</volume>. <pub-id pub-id-type="doi">10.1038/s41392-022-01251-0</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prasad</surname>, <given-names>B.C.</given-names></string-name>, and <string-name><surname>Clark</surname>, <given-names>S.G</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Wnt signaling establishes anteroposterior neuronal polarity and requires retromer in C. elegans</article-title>. <source>Development</source> <volume>133</volume>, <fpage>1757</fpage>–<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02357</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miller</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Dean</surname>, <given-names>E.S.</given-names></string-name>, <string-name><surname>Schaller</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Tuckowski</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Munneke</surname>, <given-names>A.S.</given-names></string-name>, <string-name><surname>Beydoun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pletcher</surname>, <given-names>S.D.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>S.F</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Serotonin and dopamine modulate aging in response to food odor and availability</article-title>. <source>Nat Commun</source> <volume>13</volume>, <issue>3271</issue>. <pub-id pub-id-type="doi">10.1038/s41467-022-30869-5</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Libert</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zwiener</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Vanvoorhies</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Roman</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Pletcher</surname>, <given-names>S.D</given-names></string-name></person-group>. (<year>2007</year>). <article-title>Regulation of Drosophila life span by olfaction and food-derived odors</article-title>. <source>Science</source> <volume>315</volume>, <fpage>1133</fpage>–<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1126/science.1136610</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Kitto</surname>, <given-names>E.S.</given-names></string-name>, <string-name><surname>Beydoun</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>S.F.</given-names></string-name></person-group> (<year>2024</year>). <article-title>Food touch limits lifespan through bioamine and neuroendocrine signaling</article-title>. <source>bioRxiv</source>, 2024.2004.2019.590228. <pub-id pub-id-type="doi">10.1101/2024.04.19.590228</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grady</surname>, <given-names>D.L.</given-names></string-name>, <string-name><surname>Thanos</surname>, <given-names>P.K.</given-names></string-name>, <string-name><surname>Corrada</surname>, <given-names>M.M.</given-names></string-name>, <string-name><surname>Barnett</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Ciobanu</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Shustarovich</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Napoli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Moyzis</surname>, <given-names>A.G.</given-names></string-name>, <string-name><surname>Grandy</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rubinstein</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2013</year>). <article-title>DRD4 genotype predicts longevity in mouse and human</article-title>. <source>J Neurosci</source> <volume>33</volume>, <fpage>286</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3515-12.2013</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Veuthey</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Giunti</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rosa</surname>, <given-names>D.J.M.</given-names></string-name>, <string-name><surname>Alkema</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Rayes</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2024</year>). <article-title>The neurohormone tyramine stimulates the secretion of an Insulin-Like Peptide from the Caenorhabditis elegans intestine to modulate the systemic stress response</article-title>. <source>PLOS Biology</source> <volume>23</volume>(<issue>1</issue>): <elocation-id>e3002997</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3002997</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Özbey</surname>, <given-names>N.P.</given-names></string-name>, <string-name><surname>Imanikia</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Krueger</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hardege</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Morud</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sheng</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schafer</surname>, <given-names>W.R.</given-names></string-name>, <string-name><surname>Casanueva</surname>, <given-names>M.O.</given-names></string-name>, and <string-name><surname>Taylor</surname>, <given-names>R.C</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Tyramine Acts Downstream of Neuronal XBP-1s to Coordinate Inter-tissue UPR</article-title>. <source>Dev Cell</source> <volume>55</volume>, <fpage>754</fpage>–<lpage>770.e756.</lpage> <pub-id pub-id-type="doi">10.1016/j.devcel.2020.10.024</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Rosa</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Veuthey</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Florman</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>M.G.</given-names></string-name>, <string-name><surname>Andersen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Donnelly</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rayes</surname>, <given-names>D.</given-names></string-name>, and <string-name><surname>Alkema</surname>, <given-names>M.J.</given-names></string-name></person-group> (<year>2019</year>). <article-title>The flight response impairs cytoprotective mechanisms by activating the insulin pathway</article-title>. <source>Nature</source> <volume>573</volume>, <fpage>135</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1524-5</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Riera</surname>, <given-names>C.E.</given-names></string-name>, <string-name><surname>Huising</surname>, <given-names>M.O.</given-names></string-name>, <string-name><surname>Follett</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Leblanc</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Halloran</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Van Andel</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>de Magalhaes Filho</surname>, <given-names>C.D.</given-names></string-name>, <string-name><surname>Merkwirth</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Dillin</surname>, <given-names>A.</given-names></string-name></person-group> (<year>2014</year>). <article-title>TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling</article-title>. <source>Cell</source> <volume>157</volume>, <fpage>1023</fpage>–<lpage>1036</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.051</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolkow</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Kimura</surname>, <given-names>K.D.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>M.S.</given-names></string-name>, and <string-name><surname>Ruvkun</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2000</year>). <article-title>Regulation of C. elegans life-span by insulinlike signaling in the nervous system</article-title>. <source>Science</source> <volume>290</volume>, <fpage>147</fpage>–<lpage>150</lpage>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boylston</surname>, <given-names>W.H.</given-names></string-name>, <string-name><surname>DeFord</surname>, <given-names>J.H.</given-names></string-name>, and <string-name><surname>Papaconstantinou</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Identification of longevity-associated genes in long-lived Snell and Ames dwarf mice</article-title>. <source>Age (Dordr)</source> <volume>28</volume>, <fpage>125</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-006-9008-6</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blüher</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kahn</surname>, <given-names>B.B.</given-names></string-name>, and <string-name><surname>Kahn</surname>, <given-names>C.R</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Extended longevity in mice lacking the insulin receptor in adipose tissue</article-title>. <source>Science</source> <volume>299</volume>, <fpage>572</fpage>–<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1126/science.1078223</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kappeler</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>De Magalhaes Filho</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Dupont</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Leneuve</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cervera</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Périn</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Loudes</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Blaise</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Klein</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Epelbaum</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism</article-title>. <source>PLoS Biol</source> <volume>6</volume>, <fpage>e254</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0060254</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holzenberger</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dupont</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ducos</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Leneuve</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Géloën</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Even</surname>, <given-names>P.C.</given-names></string-name>, <string-name><surname>Cervera</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Le Bouc</surname>, <given-names>Y.</given-names></string-name></person-group> (<year>2003</year>). <article-title>IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice</article-title>. <source>Nature</source> <volume>421</volume>, <fpage>182</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1038/nature01298</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Purkayastha</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Cai</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH</article-title>. <source>Nature</source> <volume>497</volume>, <fpage>211</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1038/nature12143</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miller</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Dean</surname>, <given-names>E.S.</given-names></string-name>, <string-name><surname>Pletcher</surname>, <given-names>S.D.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>S.F</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Cell non-autonomous regulation of health and longevity</article-title>. <source>eLife</source> <volume>9</volume>. <pub-id pub-id-type="doi">10.7554/eLife.62659</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Nettleton</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>S.K.</given-names></string-name>, and <string-name><surname>Powell-Coffman</surname>, <given-names>J.A</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in <italic>Caenorhabditis elegans</italic></article-title>. <source>J Biol Chem</source> <volume>280</volume>, <fpage>20580</fpage>–<lpage>20588</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M501894200</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Epstein</surname>, <given-names>A.C.R.</given-names></string-name>, <string-name><surname>Gleadle</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>McNeill</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Hewitson</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>O’Rourke</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mole</surname>, <given-names>D.R.</given-names></string-name>, <string-name><surname>Mukherji</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Metzen</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>M.I.</given-names></string-name>, <string-name><surname>Dhanda</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2001</year>). <article-title>C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation</article-title>. <source>Cell</source> <volume>107</volume>, <fpage>43</fpage>–<lpage>54</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaeberlein</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Kapahi</surname>, <given-names>P</given-names></string-name></person-group>. (<year>2009</year>). <article-title>The hypoxic response and aging</article-title>. <source>Cell Cycle</source> <volume>8</volume>, <issue>2324</issue>. <fpage>9126</fpage> [pii].</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muller</surname>, <given-names>R.U.</given-names></string-name>, <string-name><surname>Fabretti</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zank</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Burst</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Benzing</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Schermer</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2009</year>). <article-title>The von Hippel Lindau Tumor Suppressor Limits Longevity</article-title>. <source>J Am Soc Nephrol</source> <volume>20</volume>, <fpage>2513</fpage>–<lpage>2517</lpage>. ASN.2009050497 [pii] <pub-id pub-id-type="doi">10.1681/ASN.2009050497</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leiser</surname>, <given-names>S.F.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Rossner</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Fletcher</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Leonard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Primitivo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rintala</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ramos</surname>, <given-names>F.J.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>D.L.</given-names></string-name>, and <string-name><surname>Kaeberlein</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Cell nonautonomous activation of flavin-containing monooxygenase promotes longevity and health span</article-title>. <source>Science</source>. <pub-id pub-id-type="doi">10.1126/science.aac9257</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rogers</surname>, <given-names>S.R.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Durham</surname>, <given-names>J.T.</given-names></string-name>, <string-name><surname>Stefely</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Owiti</surname>, <given-names>A.N.</given-names></string-name>, <string-name><surname>Markhard</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Sandler</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>To</surname>, <given-names>T.-L.</given-names></string-name>, and <string-name><surname>Mootha</surname>, <given-names>K.V</given-names></string-name></person-group>. (<year>2023</year>). <article-title>Hypoxia extends lifespan and neurological function in a mouse model of aging</article-title>. <source>PLOS Biology</source> <volume>21</volume>, <fpage>e3002117</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3002117</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>M.-S.</given-names></string-name>, <string-name><surname>Otecko</surname>, <given-names>O.N.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>D.-D.</given-names></string-name>, and <string-name><surname>Zhang</surname>, <given-names>Y.-P</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Hypoxia potentially promotes Tibetan longevity</article-title>. <source>Cell Research</source> <volume>27</volume>, <fpage>302</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2016.105</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burtscher</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Effects of Living at Higher Altitudes on Mortality: A Narrative Review</article-title>. <source>Aging and Disease</source>. <pub-id pub-id-type="doi">10.14336/AD.2014.0500274</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Taber</surname>, <given-names>C.C.</given-names></string-name>, <string-name><surname>Ferens</surname>, <given-names>F.G.</given-names></string-name>, and <string-name><surname>Tarade</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata</article-title>. <source>eLife</source> <volume>11</volume>. <pub-id pub-id-type="doi">10.7554/eLife.80774</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wind</surname>, <given-names>J.J.</given-names></string-name>, and <string-name><surname>Lonser</surname>, <given-names>R.R</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Management of von Hippel-Lindau disease-associated CNS lesions</article-title>. <source>Expert Rev Neurother</source> <volume>11</volume>, <fpage>1433</fpage>–<lpage>1441</lpage>. <pub-id pub-id-type="doi">10.1586/ern.11.124</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lonser</surname>, <given-names>R.R.</given-names></string-name>, <string-name><surname>Glenn</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Walther</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chew</surname>, <given-names>E.Y.</given-names></string-name>, <string-name><surname>Libutti</surname>, <given-names>S.K.</given-names></string-name>, <string-name><surname>Linehan</surname>, <given-names>W.M.</given-names></string-name>, and <string-name><surname>Oldfield</surname>, <given-names>E.H</given-names></string-name></person-group>. (<year>2003</year>). <article-title>von Hippel-Lindau disease</article-title>. <source>Lancet</source> <volume>361</volume>, <fpage>2059</fpage>–<lpage>2067</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)13643-4</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaelin</surname>, <given-names>W.G</given-names></string-name></person-group>. (<year>2002</year>). <article-title>Molecular basis of the VHL hereditary cancer syndrome</article-title>. <source>Nat Rev Cancer</source> <volume>2</volume>, <fpage>673</fpage>–<lpage>682</lpage>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhat</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Carranza</surname>, <given-names>R.F.</given-names></string-name>, <string-name><surname>Tuckowski</surname>, <given-names>M.A.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>F.S</given-names></string-name></person-group>. (<year>2024</year>). <article-title>Flavin-containing monooxygenase (FMO): Beyond xenobiotics</article-title>. <source>BioEssays</source> <volume>46</volume>. <pub-id pub-id-type="doi">10.1002/bies.202400029</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pocock</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Hobert</surname>, <given-names>O.</given-names></string-name></person-group> (<year>2008</year>). <article-title>Oxygen levels affect axon guidance and neuronal migration in <italic>Caenorhabditis elegans</italic></article-title>. <source>Nat Neurosci</source> <volume>11</volume>, <fpage>894</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2152</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sze</surname>, <given-names>J.Y.</given-names></string-name>, <string-name><surname>Victor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Loer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Ruvkun</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2000</year>). <article-title>Food and metabolic signalling defects in a <italic>Caenorhabditis elegans</italic> serotonin-synthesis mutant</article-title>. <source>Nature</source> <volume>403</volume>, <fpage>560</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1038/35000609</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flavell</surname>, <given-names>S.W.</given-names></string-name>, <string-name><surname>Pokala</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Macosko</surname>, <given-names>E.Z.</given-names></string-name>, <string-name><surname>Albrecht</surname>, <given-names>D.R.</given-names></string-name>, <string-name><surname>Larsch</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Bargmann</surname>, <given-names>C.I</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Serotonin and the neuropeptide PDF initiate and extend opposing behavioral states in C. elegans</article-title>. <source>Cell</source> <volume>154</volume>, <fpage>1023</fpage>–<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.08.001</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hobson</surname>, <given-names>R.J.</given-names></string-name>, <string-name><surname>Hapiak</surname>, <given-names>V.M.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Buehrer</surname>, <given-names>K.L.</given-names></string-name>, <string-name><surname>Komuniecki</surname>, <given-names>P.R.</given-names></string-name>, and <string-name><surname>Komuniecki</surname>, <given-names>R.W</given-names></string-name></person-group>. (<year>2006</year>). <article-title>SER-7, a <italic>Caenorhabditis elegans</italic> 5-HT7-like receptor, is essential for the 5-HT stimulation of pharyngeal pumping and egg laying</article-title>. <source>Genetics</source> <volume>172</volume>, <fpage>159</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.105.044495</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carre-Pierrat</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baillie</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Johnsen</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hyde</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hart</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Granger</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Ségalat</surname>, <given-names>L</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Characterization of the <italic>Caenorhabditis elegans</italic> G protein-coupled serotonin receptors</article-title>. <source>Invert Neurosci</source> <volume>6</volume>, <fpage>189</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/s10158-006-0033-z</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taylor</surname>, <given-names>S.R.</given-names></string-name>, <string-name><surname>Santpere</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Weinreb</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Barrett</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Reilly</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Varol</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Oikonomou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Glenwinkel</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McWhirter</surname>, <given-names>R.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Molecular topography of an entire nervous system</article-title>. <source>Cell</source> <volume>184</volume>, <fpage>4329</fpage>–<lpage>4347.e4323.</lpage> <pub-id pub-id-type="doi">10.1016/j.cell.2021.06.023</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turek</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Besseling</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Spies</surname>, <given-names>J.-P.</given-names></string-name>, <string-name><surname>König</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Bringmann</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Sleep-active neuron specification and sleep induction require FLP-11 neuropeptides to systemically induce sleep</article-title>. <source>eLife</source> <volume>5</volume>. <pub-id pub-id-type="doi">10.7554/eLife.12499</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Banerjee</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bhattacharya</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gorczyca</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Collins</surname>, <given-names>M.K.</given-names></string-name>, and <string-name><surname>Francis</surname>, <given-names>M.M</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Local neuropeptide signaling modulates serotonergic transmission to shape the temporal organization of C. elegans egg-laying behavior</article-title>. <source>PLOS Genetics</source> <volume>13</volume>, <fpage>e1006697</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006697</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bauknecht</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Jékely</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians</article-title>. <source>BMC Biology</source> <volume>15</volume>. <pub-id pub-id-type="doi">10.1186/s12915-016-0341-7</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alkema</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Hunter-Ensor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ringstad</surname>, <given-names>N.</given-names></string-name>, and <string-name><surname>Horvitz</surname>, <given-names>H.R</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Tyramine Functions independently of octopamine in the <italic>Caenorhabditis elegans</italic> nervous system</article-title>. <source>Neuron</source> <volume>46</volume>, <fpage>247</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.02.024</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hobert</surname>, <given-names>O</given-names></string-name></person-group>. (<year>2013</year>). <article-title>The neuronal genome of <italic>Caenorhabditis elegans</italic></article-title>. <source>WormBook</source>, 1-106. <pub-id pub-id-type="doi">10.1895/wormbook.1.161.1</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rex</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Molitor</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Hapiak</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Henderson</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Komuniecki</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Tyramine receptor (SER-2) isoforms are involved in the regulation of pharyngeal pumping and foraging behavior in <italic>Caenorhabditis elegans</italic></article-title>. <source>J Neurochem</source> <volume>91</volume>, <fpage>1104</fpage>–<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02787.x</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pirri</surname>, <given-names>J.K.</given-names></string-name>, <string-name><surname>McPherson</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Donnelly</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Francis</surname>, <given-names>M.M.</given-names></string-name>, and <string-name><surname>Alkema</surname>, <given-names>M.J</given-names></string-name></person-group>. (<year>2009</year>). <article-title>A tyramine-gated chloride channel coordinates distinct motor programs of a <italic>Caenorhabditis elegans</italic> escape response</article-title>. <source>Neuron</source> <volume>62</volume>, <fpage>526</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.04.013</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wragg</surname>, <given-names>R.T.</given-names></string-name>, <string-name><surname>Hapiak</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>S.B.</given-names></string-name>, <string-name><surname>Harris</surname>, <given-names>G.P.</given-names></string-name>, <string-name><surname>Gray</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Komuniecki</surname>, <given-names>P.R.</given-names></string-name>, and <string-name><surname>Komuniecki</surname>, <given-names>R.W</given-names></string-name></person-group>. (<year>2007</year>). <article-title>Tyramine and octopamine independently inhibit serotonin-stimulated aversive behaviors in <italic>Caenorhabditis elegans</italic> through two novel amine receptors</article-title>. <source>J Neurosci</source> <volume>27</volume>, <fpage>13402</fpage>–<lpage>13412</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3495-07.2007</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rex</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Hapiak</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Hobson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Komuniecki</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2005</year>). <article-title>TYRA-2 (F01E11.5): a <italic>Caenorhabditis elegans</italic> tyramine receptor expressed in the MC and NSM pharyngeal neurons</article-title>. <source>Journal of Neurochemistry</source> <volume>94</volume>, <fpage>181</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03180.x</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zimmer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gray</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Pokala</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Karow</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Marletta</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Hudson</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Morton</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Chronis</surname>, <given-names>N.</given-names></string-name>, and <string-name><surname>Bargmann</surname>, <given-names>C.I</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Neurons detect increases and decreases in oxygen levels using distinct guanylate cyclases</article-title>. <source>Neuron</source> <volume>61</volume>, <fpage>865</fpage>–<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.02.013</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bretscher</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Kodama-Namba</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Busch</surname>, <given-names>E.K.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Soltesz</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Laurent</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Bono</surname>, <given-names>D.M</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Temperature, Oxygen, and Salt-Sensing Neurons in C. elegans Are Carbon Dioxide Sensors that Control Avoidance Behavior</article-title>. <source>Neuron</source> <volume>69</volume>, <fpage>1099</fpage>–<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.023</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hallem</surname>, <given-names>A.E.</given-names></string-name>, and <string-name><surname>Sternberg</surname>, <given-names>W.P</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Acute carbon dioxide avoidance in <italic>Caenorhabditis elegans</italic></article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>105</volume>, <fpage>8038</fpage>–<lpage>8043</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707469105</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Altun</surname>, <given-names>Z.F.</given-names></string-name>, and <string-name><surname>Hall</surname>, <given-names>D.H.</given-names></string-name></person-group>. <year>2012</year> <chapter-title>Handbook of C. elegans Anatomy</chapter-title>. <person-group person-group-type="editor"><string-name><surname>Herndon</surname>, <given-names>L.A.</given-names></string-name></person-group> (Ed.) <source>WormAtlas</source>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noble</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Stieglitz</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Srinivasan</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2013</year>). <article-title>An integrated serotonin and octopamine neuronal circuit directs the release of an endocrine signal to control C. elegans body fat</article-title>. <source>Cell Metab</source> <volume>18</volume>, <fpage>672</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2013.09.007</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Speese</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Petrie</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schuske</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ailion</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ann</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Iwasaki</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Jorgensen</surname>, <given-names>E.M.</given-names></string-name>, and <string-name><surname>Martin</surname>, <given-names>T.F</given-names></string-name></person-group>. (<year>2007</year>). <article-title>UNC-31 (CAPS) is required for dense-core vesicle but not synaptic vesicle exocytosis in <italic>Caenorhabditis elegans</italic></article-title>. <source>J Neurosci</source> <volume>27</volume>, <fpage>6150</fpage>–<lpage>6162</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1466-07.2007</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palamiuc</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Noble</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Witham</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ratanpal</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Vaughan</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Srinivasan</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2017</year>). <article-title>A tachykinin-like neuroendocrine signalling axis couples central serotonin action and nutrient sensing with peripheral lipid metabolism</article-title>. <source>Nature Communications</source> <volume>8</volume>, <fpage>14237</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms14237</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Neuropeptides</article-title>. <source>WormBook</source>, 1-36. <pub-id pub-id-type="doi">10.1895/wormbook.1.142.1</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacob</surname>, <given-names>C.T.</given-names></string-name>, and <string-name><surname>Kaplan</surname>, <given-names>M.J</given-names></string-name></person-group>. (<year>2003</year>). <article-title>The EGL-21 Carboxypeptidase E Facilitates Acetylcholine Release at <italic>Caenorhabditis elegans</italic> Neuromuscular Junctions</article-title>. <source>The Journal of Neuroscience</source> <volume>23</volume>, <fpage>2122</fpage>–<lpage>2130</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-06-02122.2003</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thacker</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Rose</surname>, <given-names>M.A</given-names></string-name></person-group>. (<year>2000</year>). <article-title>A look at the <italic>Caenorhabditis elegans</italic> Kex2/Subtilisin-like proprotein convertase family</article-title>. <source>BioEssays</source> <volume>22</volume>, <fpage>545</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1521-1878(200006)22:6&lt;545::AID-BIES7&gt;3.0.CO;2-F</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname>, <given-names>J.A.</given-names></string-name>, and <string-name><surname>Bargmann</surname>, <given-names>I.C</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Hypoxia and the HIF-1 transcriptional pathway reorganize a neuronal circuit for oxygen-dependent behavior in <italic>Caenorhabditis elegans</italic></article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>105</volume>, <fpage>7321</fpage>–<lpage>7326</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0802164105</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Powell-Coffman</surname>, <given-names>J.A.</given-names></string-name>, and <string-name><surname>Coffman</surname>, <given-names>C.R</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Apoptosis: Lack of oxygen aids cell survival</article-title>. <source>Nature</source> <volume>465</volume>, <fpage>554</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1038/465554a</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kruempel</surname>, <given-names>J.C.P.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Schaller</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Fretz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Howington</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sarker</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>S.F</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Hypoxic response regulators RHY-1 and EGL-9/PHD promote longevity through a VHL-1-independent transcriptional response</article-title>. <source>Geroscience</source> <volume>42</volume>, <fpage>1621</fpage>–<lpage>1633</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-020-00194-0</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Costa</surname>, <given-names>S.W.</given-names></string-name>, <string-name><surname>Auwera</surname>, <given-names>D.V.P.</given-names></string-name>, <string-name><surname>Glock</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Liewald</surname>, <given-names>F.J.</given-names></string-name>, <string-name><surname>Bach</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schüler</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wabnig</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Oranth</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Masurat</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bringmann</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>A GABAergic and peptidergic sleep neuron as a locomotion stop neuron with compartmentalized Ca2+ dynamics</article-title>. <source>Nature Communications</source> <volume>10</volume>. <pub-id pub-id-type="doi">10.1038/s41467-019-12098-5</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Masurat</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Preis</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Bringmann</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Sleep Counteracts Aging Phenotypes to Survive Starvation-Induced Developmental Arrest in C. elegans</article-title>. <source>Curr Biol</source> <volume>28</volume>, <fpage>3610</fpage>–<lpage>3624.e3618.</lpage> <pub-id pub-id-type="doi">10.1016/j.cub.2018.10.009</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Busack</surname>, <given-names>I.</given-names></string-name>, and <string-name><surname>Bringmann</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2023</year>). <article-title>A sleep-active neuron can promote survival while sleep behavior is disturbed</article-title>. <source>PLOS Genetics</source> <volume>19</volume>, <fpage>e1010665</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1010665</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bazopoulou</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chaudhury</surname>, <given-names>A.R.</given-names></string-name>, <string-name><surname>Pantazis</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Chronis</surname>, <given-names>N</given-names></string-name></person-group>. (<year>2017</year>). <article-title>An automated compound screening for anti-aging effects on the function of C. elegans sensory neurons</article-title>. <source>Sci Rep</source> <volume>7</volume>, <issue>9403</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-09651-x</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petrascheck</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ye</surname>, <given-names>X.</given-names></string-name>, and <string-name><surname>Buck</surname>, <given-names>L.B</given-names></string-name></person-group>. (<year>2009</year>). <article-title>A high-throughput screen for chemicals that increase the lifespan of <italic>Caenorhabditis elegans</italic></article-title>. <source>Ann N Y Acad Sci</source> <volume>1170</volume>, <fpage>698</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04377.x</pub-id>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cox</surname>, <given-names>R.L.</given-names></string-name>, <string-name><surname>Tuckowski</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Beydoun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bhat</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Howington</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Sarker</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ruwe</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2024</year>). <article-title>Fmo induction as a tool to screen for pro-longevity drugs</article-title>. <source>Geroscience</source> <volume>46</volume>, <fpage>4689</fpage>–<lpage>4706</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-024-01207-y</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chase</surname>, <given-names>D.L.</given-names></string-name>, and <string-name><surname>Koelle</surname>, <given-names>M.R</given-names></string-name></person-group>. (<year>2007</year>). <article-title>Biogenic amine neurotransmitters in C. elegans</article-title>. <source>WormBook</source>, 1-15. <pub-id pub-id-type="doi">10.1895/wormbook.1.132.1</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berkowitz</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Caldwell</surname>, <given-names>G.A.</given-names></string-name>, and <string-name><surname>Caldwell</surname>, <given-names>K.A</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Generation of stable transgenic C. elegans using microinjection</article-title>. <source>J Vis Exp</source>. <pub-id pub-id-type="doi">10.3791/833</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kitto</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Dean</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Leiser</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2025</year>). <article-title>findWormz is a user-friendly automated fluorescence quantification method for C. elegans research</article-title>. <source>microPublication Biology</source>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107651.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sylvia</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Cornell University</institution>
</institution-wrap>
<city>Ithaca</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Fundamental</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>fundamental</bold> study identifies specific neural mechanisms through which HIF-1 signaling in ADF serotonergic neurons extends lifespan in C. elegans, revealing that downstream signaling in multiple types of neurons, as well as other neuromodulators like GABA, tyramine, and NLP-17, is required for this effect. The strength of the evidence is largely <bold>convincing</bold>, as the authors establish the necessity and causality of key neuronal components using multiple genetic tools and functional dissection in a well-validated model organism.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107651.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this study by Kitto et al., the authors set out to identify specific signaling components regulating the hypoxic response from the neurons to the periphery and which components are required for lifespan extension. Their previous work had shown that expression of a stabilized HIF-1 mutant in the nervous system extends lifespan through the serotonin receptor SER-7 and leads to the induction of fmo-2 in the intestine. In the current study, they mapped the precise neural circuits required for this response, as well as the signaling mediators. Their work reveals that neurotransmitters GABA and tyramine, and the neuropeptide NLP-17, act downstream of neuronal HIF-1 to convey a &quot;hypoxic signal&quot; to peripheral tissues. Through cell-type-specific expression studies, targeted knockouts, and comprehensive lifespan analysis, the authors provide robust evidence to support their conclusions. The insights gained from the study are both moving the field forward as they advance our understanding of neuro-peripheral hypoxic signaling, but they also lay the groundwork for potential therapeutic strategies aimed at the modulation of such signaling pathways.</p>
<p>Strengths:</p>
<p>(1) This study provides new evidence further delineating signaling components required for hypoxic signaling-mediated longevity, from the nervous system to the periphery. Using a rigorous approach where they express stabilized HIF-1 mutant selectively in ADF, NSM, and HSN serotonergic neurons, followed by cell-type-specific tph-1 knockouts to pinpoint ADF-dependent serotonin signaling as essential for both lifespan extension and intestinal fmo-2 induction.</p>
<p>This was followed by generating 11 transgenic lines that drive SER-7 expression under distinct neuron-specific promoters, to systematically tease out in which of 27 candidate neurons SER-7 functions to mediate hypoxia-induced longevity. This ultimately highlighted the RIS interneuron as the required signaling hub.</p>
<p>(2) As the intestine lacks direct neuronal innervation, the authors employ neuron-specific RNAi (TU3311 strain) and dense core vesicle analyses to identify that the neuropeptide NLP-17 is required to transmit the hypoxic signal from RIS to induce fmo-2 in the intestine.</p>
<p>(3) Overall, the paper is very well written. The experiments were carried out carefully and thoroughly, and the conclusions drawn are also well supported by the results they are showing.</p>
<p>Weaknesses:</p>
<p>Overall, I don't see many weaknesses. One point relates to their read-outs, which rely heavily on lifespan measurements and fmo-2 induction without evaluating other physiological processes that serotonin or NLP-17 might affect. For translational relevance, it would be valuable to assess or mention potential adverse effects, such as changes in reproduction, pharyngeal pumping, or proteostasis capacity (proteostasis capacity specifically in the tissue showing fmo-2 upregulation).</p>
<p>While lifespan assays and fmo-2 expression do provide strong evidence, incorporating additional markers of stress resistance could strengthen the link between hypoxic signaling and organismal health as well.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107651.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors aimed to identify the specific neurons, neurotransmitters, and neuropeptides that mediate the longevity effects of the hypoxic response in C. elegans. By genetically dissecting the pathway downstream of HIF-1, they define a neural circuit involving ADF serotonergic neurons, the SER-7 receptor in the RIS interneuron, tyraminergic signaling from RIM, and neuropeptide NLP-17, ultimately linking neuronal hypoxic sensing to pro-longevity signaling in the intestine.</p>
<p>Strengths:</p>
<p>The study employs a diverse genetic toolkit, including neuron-specific transgenes, tissue-specific knockouts and rescues, RNAi knockdowns, allowing the authors to pinpoint causality, sufficiency, and necessity with high resolution. The comprehensive mapping of cell-nonautonomous signaling adds depth to our understanding of how HIF and serotonin signaling interface with aging pathways. The conclusions are supported by consistent survival assays and fmo-2 gene expression analyses.</p>
<p>Weaknesses:</p>
<p>A key limitation is the lack of clear evidence showing epistasis of so many identified molecular/neuronal components downstream of HIF-1 and serotonin. Thus, the mechanisms of how a diverse set of molecules/neurons coordinate and mediate neuronal HIF-1 effects on intestinal fmo-2 and longevity remain murky. Some rescue strategies may inadvertently cause non-physiological expression. Additionally, environmental hypoxia was not tested in parallel, so the claim on &quot;hypoxia respone&quot; throughout the manuscript is not justified by genetic manipulation alone, and the translational relevance of the genetic manipulations remains somewhat uncertain.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107651.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study found that ADF serotonergic neurons have a significant role in extending lifespan mediated by HIF-1, as well as serotonin receptor SER-7 in the GABAergic RIS interneurons. The author focuses on the sufficiency and necessity of components from the central nervous system and how they contribute to aging upon hypoxia.</p>
<p>Previous work from the lab has identified that the stabilization of HIF-1 in neurons is sufficient to extend lifespan through the serotonin receptor, SER-7, which subsequently activates fmo-2 in the intestine and leads to lifespan extension. Building on this, the author sought to determine which serotonergic neurons are involved and found that serotonin signaling in ADF neurons is required for lifespan extension mediated by HIF-1.</p>
<p>The author next tested which subset of neurons requires Ser-7 expression to rescue hypoxic response. They found that ser-7 expression in multiple neurons is sufficient to induce fmo-2, with the top candidate being the RIS neuron. Ablation of the RIS neuron did not extend lifespan, suggesting that ser-7 expression in the RIS neuron is required for lifespan extension, positioning it as a key component in the longevity signaling pathway.</p>
<p>The author also investigated neurotransmitters and found that GABA and tyramine are important components in this circuit. They showed that the tyramine receptor called tyra-3 is required for vhl-1-mediated longevity. Given that tyra-3 is expressed in oxygen- and carbon dioxide-sensing neurons, the author demonstrated that these sensing neurons work downstream of serotonin signaling. Lastly, the author screened neuropeptide/receptor binding pairs and identified NLP-17 as playing a role in hypoxia-mediated longevity.</p>
<p>Originality and Significance:</p>
<p>This research is significant in that it uncovers components that are sufficient and necessary for lifespan extension via the hypoxic response. It provides comprehensive data supporting longevity induced by HIF-1-mediated hypoxic response, in conjunction with fmo-2, a longevity gene, as demonstrated in previous work from the lab. Moreover, it provides a number of new transgenic worm tools for C. elegans and aging communities.</p>
<p>Data and Methodology:</p>
<p>(1) The experiments were thoroughly conducted, especially the generations of strains using different neuron-type promoters and crossing into mutant strains to demonstrate sufficiency and necessity.</p>
<p>(2) Some figure legends from the text do not match what the data show. (Figure 6E, F, G).</p>
<p>(3) The lifespan graph legends are confusing and could use some revamping for better clarification.</p>
<p>Conclusions:</p>
<p>This study provides insights into how hypoxic response regulates aging in a cell non-autonomous manner, outlining a potential circuit involving neurons, neurotransmitters, and neuropeptides.</p>
</body>
</sub-article>
</article>